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Abstract 
The First Episode Mood and Anxiety Program (FEMAP) aims to identify and treat youths 
with mood and anxiety disorders. This thesis sought to identify factors associated with 
engagement in FEMAP, based on extensive data collected by FEMAP researchers. A logistic 
regression model was built from candidate variables using purposeful selection. Of the 366 
participants offered treatment, 87% engaged in FEMAP. Quantity of alcohol consumed per 
occasion, gender, and anxiety sensitivity were found to be significant predictors of 
engagement. Gender and anxiety sensitivity interacted with each other such that at low 
anxiety sensitivity levels, the odds of engaging in FEMAP was higher for females than for 
males. At high anxiety sensitivity levels, the odds of females engaging was less than that of 
males. FEMAP may use this information to identify individuals who are less likely to engage 
in treatment to facilitate improved engagement.  
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Chapter 1  
1 Introduction 
Mood and anxiety disorders are common chronic disorders in Canada affecting much of 
the population. Many mood and anxiety disorders have their onset in youth, a time of 
important life transitions.  
The First Episode Mood and Anxiety Program (FEMAP) is a community-based 
treatment center designed to address the needs of youth. FEMAP conducts outreach, 
identification and treatment. Part of the treatment protocol included the collection of 
extensive information including demographic factors and outcome measures such as 
illness severity and functioning levels.  
The proportion of engagement in mental health treatment amongst youth varies 
widely. An understanding of the characteristics that differ among engagers and non-
engagers is not agreed upon in the literature though such information could allow 
treatment providers to identify those likely not to engage and implement strategies to 
improve engagement.  
1.1 Research Aim 
The research aims are as follows: 
1. To calculate the proportion of patients who are offered treatment at FEMAP and 
engage in treatment. 
2. To investigate the predictors of engagement in treatment using logistic regression. 
1.2 Thesis Layout 
The chapters are laid out as follows: chapter two provides background information on 
mental illness, treatment, engagement and a review of predictors of engagement from the 
literature; chapter three describes FEMAP, the program from which the data were 
obtained, and the study methods; chapter four describes the study results; and chapter five 
concludes with a discussion of the research findings.  
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Chapter 2  
2 Background 
2.1 Mental Disorders 
The World Health Organization (WHO) defines mental health as “a state of well-being in 
which the individual realizes his or her own abilities, can cope with the normal stresses of 
life, can work productively and fruitfully, and is able to make a contribution to his or her 
community” (World Health Organization, 2012, p. 12). 
Conversely, mental illnesses or mental disorders include a wide range of 
conditions that affect mood, thinking, or behaviours and are associated with substantial 
distress and impaired functioning (Government of Canada, 2006). Examples of mental 
illnesses include mood, anxiety, and psychotic disorders such as depression, bipolar 
disorder, obsessive-compulsive disorder, post-traumatic stress disorder, schizophrenia, 
eating disorders, and addictive behaviours. Mental illnesses can occur at any age; 
however, half have their onset in childhood and early adolescence and three quarters 
occur by age 24 (Kessler et al., 2005).  
2.1.1 Mood Disorders 
Mood disorders are mental illnesses that encompass depressive disorders and bipolar 
disorders. 
2.1.1.1 Depressive Disorders 
Major depressive disorder (MDD), defined by the occurrence of at least one major 
depressive episode (MDE), is a type of depressive disorder. An MDE is characterized by 
a depressed mood or loss of interest or pleasure in most activities for a period of at least 
two weeks, and at least four other symptoms experienced most of the day nearly every 
day. These symptoms include a change in sleep, appetite, or weight, impaired 
concentration, feelings of guilt or worthlessness, and thoughts of suicide (American 
Psychiatric Association, 2013). MDD has three severity levels: mild, moderate, and 
severe. The level of severity is determined by the number and severity of symptoms and 
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the degree of functional impairment. MDD is often a chronic and episodic illness with 
repeated episodes having the potential to occur throughout one’s lifetime. Within five 
years, 60% of those who have experienced a first MDE have a recurrent episode (Mueller 
et al., 1999).  Furthermore, recurrent episodes become more likely with an increase in the 
number of past episodes (Hardeveld, Spijker, De Graaf, Nolen, & Beekman, 2010; 
Mueller et al., 1999; Solomon et al., 2000).  
            Dysthymic disorders are another type of depressive disorder. They are 
characterized by a depressed mood most of the day, and for the majority of days for at 
least two years, or an irritable mood for at least one year for children and adolescents 
only. At least two of the following additional symptoms must be present: poor appetite, 
overeating, insomnia, hypersomnia, low energy, fatigue, low self-esteem, poor 
concentration, difficulty making decisions, or feelings of hopelessness (American 
Psychiatric Association, 2013).  
2.1.1.2 Bipolar Disorders 
Bipolar disorders are another type of mood disorder consisting of episodes of mania with 
or without MDEs. Manic episodes are characterized by an elevated or irritable mood 
persisting for at least one week. At least three other symptoms must be present and may 
include increased self-esteem, decreased need for sleep, increased talkativeness, and 
distractibility (American Psychiatric Association, 2013). There are two subtypes of 
bipolar disorder. Bipolar I disorder requires the occurrence of at least one manic episode 
and often involves MDEs, though these are not required for a bipolar I diagnosis. Bipolar 
II disorder is characterized by instances of MDEs and hypomanic episodes (American 
Psychiatric Association, 2013). Hypomanic episodes are characterized by the same 
symptoms as manic episodes; however, the duration requirement is only four days, and 
the episode is not severe enough to cause impaired functioning (American Psychiatric 
Association, 2013). Even more so than MDD, bipolar disorders are episodic. Over 90% 
of individuals will experience recurrent episodes (Langlois, Samokhvalov, Rehm, 
Spence, & Connor Gorber, 2011). Bipolar disorders are chronic illnesses that require long 
term management (Yatham et al., 2013). Age of onset generally occurs between ages 19 
and 23 (Chengappa et al., 2003; Perlis et al., 2004). 
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2.1.2 Anxiety Disorders 
Anxiety disorders are characterized by excessive and irrational worrying and may include 
the following symptoms: fatigue, headaches, muscle tension, muscle aches, difficulty 
swallowing, trembling, sweating, or hot flushes. Anxiety disorders include social anxiety 
disorder (also called social phobia), panic disorder, and generalized anxiety disorder. 
Social anxiety disorder involves a persistent fear of social and performance situations in 
which embarrassment may occur (American Psychiatric Association, 2000). Panic 
disorder is characterized by the occurrence of panic attacks followed by at least one 
month of concern about having subsequent panic attacks (American Psychiatric 
Association, 2000). A panic attack is a period of intense fear or discomfort with at least 
four of the following additional symptoms present: heart palpitations, chest pains, nausea, 
trouble breathing, shortness of breath, chills, hot flushes, trembling or shaking, feeling 
dizzy, faint or lightheaded, numbness or tingling sensation, feeling detached from 
oneself, feelings of unreality, fear of losing control, or fear of dying. Generalized anxiety 
disorder involves excessive worrying about day to day events for a period of at least six 
months that is difficult to control. At least three of following symptoms must also be 
present: restlessness, feeling on edge, easily fatigued, difficulty concentrating, irritability, 
muscle tension, or sleep disturbances (American Psychiatric Association, 2000). Onset of 
anxiety disorders occurs early in life, typically childhood or adolescence, depending on 
the specific disorder (Canadian Psychiatric Association, 2006; Kessler et al., 2005).  
2.2 Prevalence and Impact 
2.2.1 Worldwide Prevalence 
In 2001, the WHO estimated that approximately 450 million people were suffering from 
a mental illness (World Health Organization, 2001b) and that number had risen to 615 
million by 2013 (World Health Organization, 2016b). Mental illnesses are the leading 
cause of disability worldwide (World Health Organization, 2016a). 
 Worldwide, suicide is the second most common cause of death among young 
people (World Health Organization, 2013). Depression is among the largest single cause 
of disability worldwide (Whiteford et al., 2013; World Health Organization, 2013). 
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Furthermore, mental illnesses may be experienced at a young age and disrupt important 
life transitions (Ratnasingham, Cairney, Rehm, Manson, & Kurdyak, 2012).  
2.2.2 Canadian Prevalence 
In Canada, the burden of illness from mental disorders is extremely high. One in five 
Canadians will experience a mental illness in their lifetime (Smetanin, P., Stiff, D., 
Briante, C., Adair, C., Ahmad, S., & Khan, 2011). Furthermore, one in seven Canadians 
used health services for mental illnesses during 2009 to 2010 (Public Health Agency of 
Canada, 2015). In Ontario, the burden of mental illness and addictions exceeds that of all 
cancers (Ratnasingham et al., 2012). It has been estimated that by 2030, mental health 
issues will be the leading cause of disability in Canada (Mathers & Loncar, 2006).  
 Mood and anxiety disorders are the most prevalent mental illnesses. The burden 
of depression is higher than the combined burden of four major cancers: lung, colorectal, 
breast, and prostate (Ratnasingham et al., 2012). The annual prevalence of mood and 
generalized anxiety disorder was estimated based on the 2012 Canadian Community 
Health Survey (CCHS). Individuals aged 15 and over were sampled and asked whether 
they had been diagnosed with a mood or anxiety disorder by a health professional. The 
12-month prevalence of major depressive disorder, bipolar disorders, and generalized 
anxiety disorder were 4.7%, 1.5%, and 2.6%, respectively. The prevalence of depression 
was stratified by age and sex. The one-year prevalence in females was 9.0%, 6.8%, 5.6%, 
and 1.8% for age groups 15 to 24 years, 25 to 44 years, 45 to 64 years, and 65 years and 
older, respectively. In males the prevalence is consistently lower in each age group. The 
one-year prevalence was 5.3%, 4.1%, 3.4%, and 1.4% in each respective age group. For 
both males and females, the prevalence is highest amongst those aged 15 to 24 years 
(Pearson, Janz, & Ali, 2013).  
 Anxiety and depressive disorders are often comorbid conditions. Approximately 
one quarter (24.9%) of Canadians with past year MDD also reported generalized anxiety 
disorder (Patten et al., 2015). Another study in the United States (US) found that 21% of 
adults with MDD also had an anxiety disorder, but of those with anxiety, 48% also had 
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MDD (Gwynn et al., 2008). Worldwide, estimates of any comorbid anxiety disorder with 
past year MDD range from 48.0% to 53.3% (R. C. Kessler et al., 2015).  
 Each of MDD, bipolar disorders, and anxiety disorders are associated with an 
increased risk of suicide. The rates of suicide are between 10 and 20 times higher for 
those with MDD, bipolar disorder, or anxiety disorder compared to the general 
population (Canadian Psychiatric Association, 2006; Langlois et al., 2011; Patten et al., 
2015; Yatham et al., 2013). 
2.3 Treatment 
Treatment for mental illnesses typically includes psychotherapy and pharmacotherapy. 
Alternative therapies include exercise therapy, light therapy and relaxation techniques 
such as yoga or meditation (Cooney et al., 2013; Cramer et al., 2008; Perera et al., 2016). 
Psychotherapy involves interactions between the therapist and patient outside of the use 
of medication. Currently, cognitive behavioural therapy (CBT) is the most common 
psychotherapy treatment with abundant evidence supporting its use (Harrington, 
Whittaker, Shoebridge, & Campbell, 1998; James, James, Cowdrey, Soler, & Choke, 
2015; Scaini, Belotti, Ogliari, & Battaglia, 2016). CBT can be delivered by different 
practitioners such as a psychiatrist, psychologist, social worker, or other mental health 
care providers; and in different formats e.g. individual, group, or self-directed (Canadian 
Psychiatric Association, 2006). Pharmacotherapy uses medications to treat illness and can 
include antidepressants, anti-anxiety medications, or mood stabilizing medications, 
amongst others.  
 For individuals who are not responsive to psychotherapy or pharmacotherapy, 
electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) 
are therapeutic options (MacQueen et al., 2016). ECT involves the delivery of electric 
pulses to the brain causing a generalized seizure while the patient is anesthetized, which 
can alleviate the symptoms of MDD and other mental illnesses. rTMS delivers magnetic 
pulses to the brain that can change the activity of the brain cells and improve the 
symptoms of mental illness (Barker, Jalinous, & Freeston, 1985; Croarkin et al., 2010; 
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George et al., 2010) in similar ways to ECT, but without the need for anesthesia or a 
generalized seizure.  
 Both the Canadian Network for Mood and Anxiety Treatments (CANMAT) and 
the Canadian Psychiatric Association (CPA) provide practice guidelines for the treatment 
of mood and anxiety disorders, produced by assembling effectiveness and safety 
information on available treatments (Antony et al., 2006; Kennedy et al., 2016; 
MacQueen et al., 2016; Parikh et al., 2016; Yatham et al., 2013).  
Though efficacious treatments exist for mood and anxiety disorders, adolescents’ 
engagement with and adherence to those treatments is low.  
2.4 Engagement 
The terms engagement and disengagement are used in the literature with varying 
meanings and conceptualizations. Often engagement, adherence, and compliance are used 
interchangeably, and none of these terms have standard definitions or a standard way of 
measuring them.  
 Adherence is used to describe the degree to which medical instructions are 
followed and appointments are attended. The WHO defines adherence to long term 
therapy as “the extent to which a person’s behavior – taking medication, following a diet, 
and/or executing lifestyle changes, corresponds with agreed recommendations from a 
health care provider” (De Geest & Sabaté, 2003, p. 17). Taking prescribed medications 
and attending clinical appointments are frequently considered measures of adherence. 
The timeframe for measuring adherence ranges from short, measured in weeks, to long, 
measured in years. 
 Compliance is used in a similar manner to adherence but the term compliance has 
a negative connotation when applied to patients’ uptake of health care. The term invokes 
images of patients passively following directions laid out for them (Vermeire, 
Hearnshaw, Van Royen, & Denekens, 2001). Furthermore, the term compliance may 
even carry the implication that the patient was coerced into treatment (Vuckovich, 2010). 
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 Engagement is used to refer to a more complex process of involvement with 
health services. In the literature, the concepts of engagement and disengagement in 
mental health treatment have been defined in several different ways. Dixon et al. state 
that the goal of engagement is to “develop a trusting relationship between the treatment 
team and the client. Engagement is successful when a client identifies the program as his 
or her service provider” (Dixon, Krauss, Kernan, Lehman, & DeForge, 1995, p. 685). 
Mowbray et al. define engagement as “the first stage which must be completed before 
clients can successfully move into the stages that follow: persuasion, active treatment, 
and relapse prevention” (Mowbray, Cohen, & Bybee, 1993, p. 338). Hall et al. measured 
aspects of engagement including appointment keeping, client-therapist interaction, 
communication/openness, client perceived usefulness of treatment, collaboration with 
treatment, and compliance with medication (Hall, Meaden, Smith, & Jones, 2001). 
O’Brien et al. define engagement as a “complex phenomenon encompassing factors that 
include acceptance of a need for help, the formation of a therapeutic alliance with 
professionals, satisfaction with the help already received, and a mutual acceptance and 
working towards shared goals” (O’Brien, Fahmy, & Singh, 2009). The definition 
provided by MacBeth et al. is similar: engagement is a “multifactorial concept that 
encompasses the acceptance of the treatment, therapeutic rapport and collaborations 
towards a shared goal of both functional and clinical recovery” (MacBeth, Gumley, 
Schwannauer, & Fisher, 2013). Similar to adherence, engagement can be measured by 
attendance at clinical appointments. The timeframe for measuring engagement also 
ranges from short, measured in weeks, to long, measured in years. Perhaps the key 
feature distinguishing adherence from engagement in these definitions is that taking 
prescribed medications is rarely the sole marker of engagement by researchers in mental 
health therapy. 
 The definition of engagement in this thesis is most closely aligned with that of 
Mowbray, in which engagement is “the first stage which must be completed before 
clients can successfully move into the stages that follow: persuasion, active treatment and 
relapse prevention” (Mowbray et al., 1993, p. 338). Engagement is the first step towards 
the acceptance of treatment, formation of a therapeutic alliance, and adherence to 
therapy.  
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2.5 Literature Review 
The literature was searched using the terms adherence, nonadherence, compliance, non-
compliance, engagement, disengagement, and dropout specifically for adolescents and 
young adults undergoing treatment for mood and anxiety disorders. The search was 
conducted in PubMed and PsycINFO databases, limited to English publications, 
observational studies thus excluded randomized controlled trials, and had no date 
restrictions. As discussed earlier, these terms represent overlapping concepts that are used 
synonymously in the literature. Given the significant overlap in the concepts, the varying 
definitions, and the similarity amongst predictors, we will discuss the adherence and 
engagement literature as a whole. When referencing specific studies, we will use the term 
cited by the original author (adherence, engagement, or compliance). The findings of this 
literature review pertain to youth experiencing mood and anxiety disorders, not 
necessarily a first-episode, treated in both in- and out-patient settings. Studies focused on 
adults were not included. The goals of the literature review were 1) identify different 
approaches to defining engagement in therapy for youth diagnosed with mood and 
anxiety disorders and 2) identify predictors of engagement in therapy for youth with 
mood and anxiety disorders, interpreting the findings using the WHO framework on 
adherence. 
2.5.1 Definitions of Engagement in Therapy  
2.5.1.1 Medication Adherence 
Studies that assessed medication adherence used a variety of measures, such as blood 
tests, requiring patients to bring in medication bottles to conduct pill counts, self-reported 
adherence by the patient or guardian, provider reported adherence, the Medication 
Adherence Rating Scale (Lucca, Ramesh, Parthasarathi, & Ram, 2015), and retrospective 
review of inpatient medication records (Timlin, Hakko, Riala, Räsänen, & Kyngäs, 
2014). The thresholds for adherence to medication also vary in the mental health 
literature. Poor medication adherence has been defined as 10 or more missed medication 
doses (Coletti, Leigh, Gallelli, & Kafantaris, 2005) or as taking prescribed medication 
less than 25% of the time (DelBello, Hanseman, Adler, Fleck, & Strakowski, 2007; Patel, 
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DelBello, Keck, & Strakowski, 2005). Partial adherence has been defined as taking 
medication 25% to 75% of the time and full adherence as taking medication more than 
75% of the time (DelBello et al., 2007; Patel et al., 2005; Timlin et al., 2014). Others 
have defined full adherence as taking medication at least 80% of the time (Fontanella, 
Bridge, Marcus, & Campo, 2011; Stewart & Baiden, 2013). Others defined full 
adherence as those who answered “yes” (Pogge, Singer, & Harvey, 2005) or “all the 
time” (Munson, Floersch, & Townsend, 2010) when asked whether they take their 
medication as prescribed. Subjective measurement of adherence such as self-report are 
subject to recall bias though one study used a shorter time frame to minimize recall bias 
(Coletti et al., 2005). 
 It has been shown that providers overestimate adherence and patients who report 
nonadherence more accurately describe their behaviour than those who claim adherent 
behaviour (De Geest & Sabaté, 2003). Furthermore, the dichotomization of medication 
adherence at a given level has been criticized as artificial because the percent of the 
medication dose may not correspond to a biological cut-off due to continuous dose-
response relationships (De Geest & Sabaté, 2003).  
2.5.1.2 Engagement in Psychotherapy 
Treatments that involve psychotherapy have used terms such as “compliance”, 
“engagement”, and “follow-through”. When a patient unilaterally chooses to stop 
treatment without the agreement of the therapist, for reasons other than symptom 
improvement, it has been referred to as dropout, noncompliance, or disengagement 
(Baruch, Gerber, & Fearon, 1998; de Haan, Boon, Vermeiren, Hoeve, & de Jong, 2015; 
Ghaziuddin, King, Hovey, Zaccagnini, & Ghaziuddin, 1999). Measurement methods 
employed in the aforementioned studies included medical record review or telephone 
interview with the patient or guardian. Studies that used a telephone interview differed on 
the timing of the interview after initial engagement. Interviews took place three months 
after discharge from hospital (Granboulan, Roudot-Thoraval, Lemerle, & Alvin, 2001), 
six to eight months after discharge (Ghaziuddin et al., 1999), or between 90 days and 18 
months post-discharge (Pogge et al., 2005). In some studies, the length of time between 
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initial treatment and measurement of engagement was not given (Baruch et al., 1998; de 
Haan et al., 2015). 
 In the literature, proportions engaging (i.e. engagement, adherence, or 
compliance) in therapy ranged from 33% to 78% (Coletti et al., 2005; de Haan et al., 
2015; DelBello et al., 2007; Fontanella et al., 2011; Ghaziuddin et al., 1999; Granboulan 
et al., 2001; King, Hovey, Brand, Wilson, & Ghaziuddin, 1997; Laurier, Lafortune, & 
Collin, 2010; Moses, 2011; Munson et al., 2010; Pelkonen, Marttunen, Laippala, & 
Lönnqvist, 2000; Stewart & Baiden, 2013; Timlin et al., 2014). Variations in definitions 
and measurements may account for the wide range of proportions. This idea is consistent 
with de Haan et al.’s 2013 study investigating reasons for the large variations in dropout 
percentages found in child and adolescent mental health treatment. They identified two 
factors, study design and definition of dropout (de Haan, Boon, de Jong, Hoeve, & 
Vermeiren, 2013). Study design refers to whether a study was an efficacy study 
(experimental study design) or an effectiveness study (observational study design) (de 
Haan et al., 2013). 
2.5.2 Engagement and Treatment Outcomes 
Despite differences in the definition and measurement of engagement, there is agreement 
that it is an important part of efficacious treatment. Poor adherence to treatment is 
associated with poorer outcomes such as increased risk of relapse and increased 
hospitalization (Bobier & Warwick, 2005; Fontanella et al., 2011). 
 Understanding factors that are associated with engagement may help treatment 
providers identify those most likely to disengage before it occurs, and to develop 
strategies to help patients remain engaged, complete treatment, reach full remission, and 
reduce the possibility of relapse. 
2.5.3 World Health Organization Framework 
The World Health Organization (WHO) published a 2003 report entitled ‘Adherence to 
long-term therapies: evidence for action’. In the report, the authors’ focused on defining 
adherence, reviewing adherence rates and reviewing factors that affect adherence for nine 
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chronic conditions. In the report, the WHO authors specify a framework for 
understanding adherence that consists of five dimensions, 1) social and economic, 2) 
health care team and system-related, 3) condition-related, 4) therapy-related, and 5) 
patient-related factors. The framework is used to organize the factors that affect 
adherence for all chronic illnesses and although the framework is not specific to mental 
illness, depression is one of the nine chronic illnesses reviewed. (De Geest & Sabaté, 
2003). The WHO framework is a useful guide to a review of the literature on factors that 
influence adherence to mental health therapies amongst youth.   
2.5.3.1 Social and Economic Factors 
The WHO dimension of social and economic factors includes socioeconomic status, 
illiteracy, low level of education, unemployment, lack of effective social support 
networks, long distance from treatment center, and high cost of medication. For some of 
these factors the mechanism that explains the relationship to adherence is straightforward, 
for example high cost of medication may reduce adherence for youth from low income 
families. The mechanism for other factors is less clear.  
Age 
In the WHO framework, age is considered a social and economic factor. It is unclear how 
age may affect adherence. Age is a marker for developmental stage. For those at younger 
ages, it may signal a lack of independence and reliance on parents for the means to attend 
therapy. Age may also signal the maturity level, knowledge and beliefs about therapy that 
may influence adherence. The literature is mixed on whether or not age is a predictor of 
engagement. Some studies have identified younger age as a predictor of engagement (de 
Haan et al., 2015; Fontanella et al., 2011; Pelkonen et al., 2000). Though Pelkonen et al. 
investigated individuals who were accepted to treatment but never attended compared to 
those who were accepted and attended treatment, there was no association with age 
(Pelkonen et al., 2000). Others have found that older age is associated with engagement 
(Baruch et al., 1998; Munson et al., 2010; Stewart & Baiden, 2013), whereas some 
studies found no association (Coletti et al., 2005; Granboulan et al., 2001; King et al., 
1997; Moses, 2011). The ages of youths in these studies ranged from 12 to 24 years,  
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Gender 
Despite prevailing belief that female patients are more compliant with mental health 
treatment, gender has rarely been found to be associated with adherence to mental health 
treatment. In fact, a study conducted at a Dutch Youth Mental Health Care Center found 
that male gender was associated with adherence (de Haan et al., 2015). Interestingly, 
most studies found no association between gender and engagement (Baruch et al., 1998; 
DelBello et al., 2007; Fontanella et al., 2011; Ghaziuddin et al., 1999; Granboulan et al., 
2001; King et al., 1997; Moses, 2011; Munson et al., 2010; Pelkonen et al., 2000; Stewart 
& Baiden, 2013). The studies did not distinguish between gender and sex, and did not 
specify how data were obtained. For example, studies did not collect information on 
biological sex in addition to gender and likely assumed 100% overlap between the two. 
The term gender is used because the mechanism used to explain engagement is likely 
socio-cultural (gender) rather than biological (sex). 
Ethno-racial Background 
The WHO report states these findings about ethno-racial background: “Race has 
frequently been reported to be a predictor of adherence, regardless of whether the 
members of a particular race are living in their country of origin or elsewhere as 
immigrants. Often, cultural beliefs are the reason behind these racial difference, but no 
less often, social inequalities confound these findings” (De Geest & Sabaté, 2003, p. 42). 
Different cultures may have different health beliefs that can influence adherence. For 
example, some cultures may attach a large degree of stigma to mental illness. Individuals 
from certain ethno-racial backgrounds also face significant social and economic 
disadvantages, for example as members of a minority group, immigrants, or non-native 
English-speakers, all of which could reduce the quality and effectiveness of health 
services and influence adherence. Several studies investigated either race or ethnicity as a 
predictor of adherence for youths with mood and anxiety disorders. The majority did not 
find a significant association (DelBello et al., 2007; Ghaziuddin et al., 1999; King et al., 
1997; Moses, 2011; Munson et al., 2010; Patel et al., 2005). Three studies did find an 
association between ethno-racial background and adherence. Ethnic minority status 
predicted continuation versus dropout from a community-based program in England 
(Baruch et al., 1998). The association was small but significant. In a Dutch study the 
14 
 
opposite result was found; for adolescents an ethnic minority status was a predictor of 
dropout, defined as leaving treatment without agreement of the treatment-provider (de 
Haan et al., 2015). Similarly, a US-based study compared adherence in non-Hispanic 
white patients to minorities and found that non-minority race was a strong predictor of 
adherence to antidepressant treatment (Fontanella et al., 2011). Differences in levels of 
acculturation across the studies may influence findings. Health system factors influencing 
the affordability of treatment may also have resulted in divergent findings. 
Socioeconomic Status/Parental Education 
It is important to note when investigating the influence of socioeconomic status (SES) on 
adherence, that SES may be measured in a variety of ways including income, occupation, 
education or a combination of these measures. SES may be a marker of the affordability 
of therapy, and this differs by health system. Public financing of mental health services 
means these may be provided for free at the point of care, otherwise services may require 
fees. A high cost at the point of care would make individuals with lower SES less likely 
to adhere to treatment. Even with no cost at the point of care, parents in lower status 
occupations may have inflexible work schedules and thus may not be available to help 
youth attend appointments. Alternatively, parental education may correlate with 
engagement in therapy because advanced education may be a marker of the acceptability 
of therapy. Previous research indicated that parents have the capacity to influence 
adherence behaviours. Coletti et al. found a relationship between parent perceptions of 
effectiveness of medication and missed medication (Coletti et al., 2005). A low SES has 
been associated with nonadherence in previous studies (de Haan et al., 2015; DelBello et 
al., 2007; Pelkonen et al., 2000). These studies used parental education level and 
occupation and did not report parental income. De Haan et al. conducted their 
investigation in the Netherlands. SES was determined using the Dutch National Centre 
for statistic information and classified using two variables, parent’s highest level of 
occupation and highest level of parent education, each categorized into three levels. Only 
parental occupation was associated with dropouts. Those with parents in the highest 
occupation level had the fewest dropouts, and those with parents in the lowest occupation 
level had the most dropouts. There was no significant association between parental 
education and adherence (de Haan et al., 2015). 
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 The Four Factor Index of Social Status’ education, occupation, sex, and marital 
status has been used to measure social status (Hollingshead, 1975). A US-based study 
found an association between low SES, as measured by the Four Factor Index of Social 
Status, and poor adherence to treatment for bipolar disorder (DelBello et al., 2007). SES 
in patients in Finland was measured using a scale based on the occupation of the guardian 
of the adolescent and found dropout was associated with low SES (Pelkonen et al., 2000). 
Other studies found no association between SES and adherence (Granboulan et al., 2001; 
King et al., 1997). Granboulan et al. categorized parents’ SES into three levels but did not 
provide additional details. King used parental employment and education similar to de 
Haan et al. A higher parental education measured in years of education was a strong 
predictor of commitment to medication treatment in adolescents (Moses, 2011). A study 
in the US used income as a predictor and found that an annual family income greater than 
50,000 USD was associated with adherence (Munson et al., 2010).  
Familial Relationships 
The nature of familial relationships may influence adherence. Youths in families with 
positive relationships may have better emotional support or experience less stigma about 
mental health services, leading to greater adherence to therapy. However, both null and 
positive results have been found for familial relationships and adherence. Timlin et al. 
used the clinician-rated Global Assessment of Relational Functioning (GARF), a measure 
of family functioning, and found significant positive associations between family 
functioning and adherence (Timlin et al., 2014). Moses used the Multidimensional Scale 
of Perceived Social Support to measure social and family support. The family subscale 
ranged from 1.25 to 7, and higher scores were associated with greater commitment to 
continuing medication in a logistic regression analysis (Moses, 2011). Two studies did 
not find any association between familial relationships and engagement. When conflict 
between adolescents and parents was investigated, no association with compliance was 
found (Granboulan et al., 2001). Nor was an association found between adolescents’ 
perceptions of family functioning measured using the Family Assessment Device and 
treatment follow-through (King et al., 1997). 
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Parents’ Marital Status 
Parental marital status may be related to adherence although the mechanism is unclear. It 
is possible that parental marital status is a marker of income, the availability of a parent 
to take youth to appointments, or the nature of familial relationships. Some studies 
investigated parental marital status and found no association with adherence (Ghaziuddin 
et al., 1999; Granboulan et al., 2001; King et al., 1997). Ghaziuddin et al. found no 
relationship between adherence and family living arrangement (biological parent, single 
parent, biological and step-parent, or non-parent). King et al. found that family caregiver 
structure (two biological parents, single biological parent, biological and step-parent, or 
non-parent) was not indicative of adherence in suicidal adolescents (King et al., 1997). In 
Parisian adolescents following a suicide attempt, parental separation at the time of 
attempt was not associated with adherence (Granboulan et al., 2001). 
Summary 
The social and economic factors investigated in the literature included age, gender, ethno-
racial background, socioeconomic status and parental education, familial relationships, 
and parental marital status. The mechanism for how each factor influences adherence is 
not clear and these may act through multiple, complex pathways. Complex mechanisms 
may explain the variation in the direction of the results. We did not find studies 
examining other factors specified in the WHO framework such as distance from the 
treatment center and cost of medication in this population.  
2.5.3.2 Patient-related factors 
Patient-related factors have been the focus of many studies. According to the WHO 
framework, “patients’ knowledge and beliefs about their illness, motivation to manage it, 
confidence (self-efficacy) in their ability to engage in illness-management behaviours, 
and expectations regarding the outcome of treatment and the consequences of poor 
adherence, interact in ways not yet fully understood to influence adherence behaviour.” 
(De Geest & Sabaté, 2003, p. 44).  For example, substance use, forgetfulness, lack of 
perceived need for treatment, lack of perceived effect of treatment, misunderstanding and 
non-acceptance of the disease, misunderstanding of treatment instructions, hopelessness 
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and negative feelings, frustration with health care providers, and feeling stigmatized by 
the disease may all influence adherence behaviours. 
According to De Geest and Sabate, authors of the WHO report, substance use is a 
patient-related that induces an altered mental state which influences adherence 
behaviours (De Geest & Sabaté, 2003). Pogge et al. suggest that substance use is a form 
of self-medication that influences medication adherence because medications may 
interfere with the rewarding properties of recreational drugs and as a result patients 
discontinue medication to allow for experiencing the rewarding properties of other 
substances. The authors also propose that substance use behaviour may reflect a general 
tendency to reject authority and medical advice (Pogge et al., 2005). 
Marijuana Use 
Cannabis use defined as any use of cannabis during the 12 months preceding admission 
has been found to be significantly associated with nonadherence for youth inpatients in 
adult mental health facilities (Stewart & Baiden, 2013). On the other hand, DelBello et al. 
did not find an association between adherence and cannabis use disorder (DelBello et al., 
2007).  
Other Illicit Drug Use 
Granboulan et al. found that illicit drug use was associated with improved compliance to 
post-discharge follow-up care in adolescents who attempted suicide (Granboulan et al., 
2001). The measure of illicit drug use was not reported.  
Other studies explored the role of substances using a diagnosis of substance use 
disorder as a predictor and found it to be negatively associated with adherence to mental 
health treatment (Pelkonen et al., 2000; Pogge et al., 2005). Fontanella et al. investigated 
the acute and maintenance phases of mental health treatment separately and found that 
the negative association between substance use disorder and antidepressant adherence 
was significant only in the maintenance phase (Fontanella et al., 2011). 
Tobacco Use 
Daily use of tobacco was associated with medication nonadherence in youth inpatients in 
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adult mental health facilities (Stewart & Baiden, 2013). Granboulan et al. did not find any 
association between tobacco use and follow-up care in adolescents who had attempted 
suicide, though the definition and measure of tobacco use was not reported (Granboulan 
et al., 2001).  
Alcohol Use 
Stewart et al. investigated the role of alcohol use defined as consumption of alcoholic 
beverages in the two weeks preceding admission, as a predictor of adherence. Alcohol 
use was found to be significantly associated with nonadherence for youth inpatients in 
adult mental health facilities in univariate analyses but did not remain significant when 
adjusted for other variables (Stewart & Baiden, 2013). DelBello et al. examined 
adherence using alcohol use disorder as a covariate but the association did not reach 
statistical significance, though none of the six adolescents with an alcohol use disorder 
were adherent (DelBello et al., 2007). Granboulan et al. did not find a significant 
association between follow-up and alcohol use greater than once per week (Granboulan et 
al., 2001).  
Satisfaction with Previous Mental Health Care 
Though patient satisfaction with care has been found to be associated with adherence to 
medical treatment (Marshall & Hays, 1994), no studies were identified that investigated 
the association between satisfaction with previous mental health services and engagement 
in current mental health treatment. 
Belief About Mental Health Treatment 
Positive attitudes and beliefs about mental health treatment have consistently been found 
to be strongly associated with adherence. Perhaps the consistent findings reflect a more 
direct pathway from belief about mental health treatment to adherence; patients who have 
a strong belief about the effectiveness of mental health treatment may be more motivated 
to adhere to treatment. Pogge et al. measured belief about medication efficacy during 
phone interviews. Adherence to medications and beliefs about efficacy were significantly 
correlated (Pogge et al., 2005). Munson et al. measured attitudes about mental health 
treatment using the adapted Attitudes toward Seeking Mental Health Services (Munson et 
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al., 2010). Adolescents with positive attitudes were more likely to be fully adherent to 
treatment.  
Self-referral 
The allowance for patient self-referral to mental health therapy is a health system factor 
that differs by country, region and possibly by practitioner. When self-referral is allowed, 
patient self-referral may serve as a proxy for the patient’s motivation in pursuing 
treatment. Few programs allow youths to self-refer. Most treatment programs require a 
referral from a health professional, consequently this factor has not been frequently 
investigated in the literature. Two studies investigated programs that allow for self-
referral. The study by Baruch et al. used data from a community-based program in 
London, England for individuals aged 12 to 25 years that allowed for self-referral 
(Baruch et al., 1998). Those who self-referred were more likely to continue treatment. In 
a Finland-based program, initial contact typically began with a telephone call from the 
adolescent, their parent, or a health care professional (Pelkonen et al., 2000). No 
differences were found in dropout rates amongst patients referred by a health care 
professional compared to other referral methods. 
Summary 
Patient-related factors such as substance use, beliefs about treatment and self-referral 
have been investigated as predictors of adherence. Belief about mental health treatment 
has been identified as a significant predictor of adherence in both studies we identified. 
Other patient-related factors, such as substance use and self-referral had mixed findings. 
2.5.3.3 Condition-related factors 
Condition-related factors are those related to the particular illness for which treatment is 
being provided. In the WHO framework, condition-related factors include aspects of the 
illness such as severity of symptoms, level of disability, availability of treatments, and  
co-morbid illnesses. 
Severity of Illness – Depression  
Comorbid depression or depression severity may influence a patient’s motivation to 
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adhere to treatment and attend appointments, and depression can affect memory and other 
aspects of cognitive functioning. Symptoms of depression may also include social 
withdrawal and hopelessness resulting in nonadherence behaviours (DiMatteo, Lepper, & 
Croghan, 2000). Severity of depression has been investigated as a predictor of treatment 
engagement with mixed results. Amongst Parisian adolescents who had attempted 
suicide, those with better treatment compliance had higher scores on the Center for 
Epidemiologic Studies – Depression Scale than their less compliant counterparts 
(Granboulan et al., 2001). In a study of adolescents with psychiatric illnesses who had 
been hospitalized, no association was found between severity of illness and post-
discharge medication compliance (Ghaziuddin et al., 1999). The adolescents had been 
diagnosed with depressive disorders, disruptive behaviour, and anxiety disorders; 
however, the measure used for severity of illness was not indicated. Conversely, Stewart 
et al. found that higher scores on the Depression Rating Scale were associated with 
medication nonadherence in adolescents treated in inpatient facilities in Ontario (Stewart 
& Baiden, 2013). In a study of former adolescent psychiatric inpatients, symptom 
severity was measured on admission by the patients’ primary therapist using the 
Derogatis Psychiatric Rating Scale. No association was found between symptom severity 
and adherence (Pogge et al., 2005).  
Severity of Illness – Anxiety 
A relationship between anxiety and adherence is not well-established with the literature 
providing mixed results. The mechanism behind a potential association is also unclear 
although anxiety may affect cognition thus affecting adherence. Higher levels of anxiety 
as measured on the Zung Anxiety Scale were associated with greater adherence to 
therapy in adolescents who had attempted suicide (Granboulan et al., 2001), yet in female 
participants treated with psychotropic medication, anxiety was negatively associated with 
compliance attitudes and behaviours (Laurier et al., 2010). Fontanella et al. and 
Ghaziuddin et al. investigated the association of anxiety disorders with medication 
adherence and found no significant association, nor was an association found by DelBello 
et al. in adolescents with bipolar disorders (DelBello et al., 2007; Fontanella et al., 2011; 
Ghaziuddin et al., 1999). Different types of anxiety disorders have very different 
symptoms which may explain the null results. Some anxiety disorders such as social 
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phobia may hinder adherence whereas obsessive-compulsive disorder may result in 
behaviours that improve adherence (DiMatteo et al., 2000). 
Functioning 
Functioning has been measured using several questionnaires including the Global 
Assessment of Functioning Scale (GAF) and the Global Assessment Scale (GAS). 
Functioning may influence adherence via similar mechanisms to disease severity. The 
GAF is used to report overall functioning by assessing psychological, social, and 
occupational functioning. Higher scores indicate better functioning. Though no longer 
endorsed in the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5), it was 
the previously endorsed rating scale in the DSM-IV (Gold, 2014). There is little research 
on the relationship between functioning and engagement. Baruch et al. found no 
relationship between GAF scores and adherence in their treatment population (Baruch et 
al., 1998). Pelkonen et al. investigated the patients’ psychosocial functioning using the 
GAS and found no differences in scores between those who did or did not drop out 
(Pelkonen et al., 2000). 
Summary 
Severity of depression, severity of anxiety, and functioning are condition-related factors 
that potentially influence adherence to therapy although the literature results are mixed.  
2.5.3.4 Health-care team and health system related factors 
Health system and health care team factors reflect how care is provided and determine the 
availability of services, length of appointments, reimbursement levels for services and 
medications, training of providers, availability of multidisciplinary care, and support to 
caregivers. According to the WHO framework, “The health care delivery system has the 
potential to affect patients’ adherence behaviour. Health care systems control access to 
care. For example, health systems control providers’ schedules, length of appointments, 
allocation of resources, fee structures, communication and information systems, and 
organizational priorities” (De Geest & Sabaté, 2003, p. 37). The quality of the health care 
team can also influence adherence behaviours through the knowledge level of the health 
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care providers, delivery of care and education to the patient, and the quality of the 
relationship between patient and physician.  
 Although health-care team and health system related factors are important, in this 
literature review we found that factors within this dimension were rarely investigated as 
predictors of adherence for youth with mental health conditions.  
A possible explanation for this lack of research is that cohort studies were 
conducted in a single center. Investigators focused on one patient population would not 
have variation in system-level factors. Health system factors were also not investigated in 
population-based studies, where the opportunity for variation in system-level factors was 
greater. One potentially important system-level factor is wait time. Longer wait-times 
may influence engagement if patient’s health status, beliefs and attitudes change during 
the wait period for services.  
2.5.3.5 Therapy-related factors 
Factors related to the treatment offered and received may affect adherence. According to 
the WHO framework, the complexity of the medical regimen, duration of treatment, 
previous treatment failures, frequent changes in treatment, immediacy of beneficial 
effects, side effects, and availability of medical support to deal with side effects can 
impact the adherence behaviours of the patient.  
Side effects 
Side effects have been associated with nonadherence in past studies of inpatients. Rapid 
weight gain during hospitalization was found to be associated with nonadherence in the 
treatment of adolescent inpatients (Pogge et al., 2005). Other side effects investigated by 
Pogge et al. such as dry mouth, memory changes, sleepiness, and akathisia, had no 
association with nonadherence. Stewart et al. found that youths who reported 
experiencing past medication side effects were significantly less likely to adhere to 
treatment (Stewart & Baiden, 2013). Side effects was not investigated as a predictor of 
adherence in any of the outpatient studies reviewed; however, 30% of noncompliant 
patients cited side effects as the reason for discontinuing medication (Ghaziuddin et al., 
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1999). The number of compliant patients who experienced side effects is not reported so 
it is unknown whether this is a significant factor that differs among adherence and non-
adherent patients. In another study, 32% of participants expressed worries about 
medication side effects (Moses, 2011). 
 Medication type 
Medication type has been investigated as a predictor of adherence in several studies. 
Medication type may influence adherence because of side effects that result from 
different medications, perceived efficacy of some medication over others, or stigma 
associated with some types of medication. The literature results on medication type are 
mixed perhaps due to the large number of types of medications included in the studies 
and the heterogeneity in diagnoses. A prescribed sleep agent was associated with greater 
adherence in the acute phase of treatment while the type of antidepressant, selective 
serotonin reuptake inhibitor compared to others,  had no association with adherence 
(Fontanella et al., 2011). In male patients, the use of a mood stabilizer was significantly 
associated with higher scores on attitudes toward medication (Laurier et al., 2010). The 
same study found that female patients taking Clonidine had poorer compliance 
behaviours (Laurier et al., 2010). Another study found that dropping out of treatment 
early was associated with not receiving a psychotropic medication (Pelkonen et al., 
2000). Many studies investigated a potential relationship with type of medication and 
adherence but did not find significant associations. Ghaziuddin et al. compared each of 
antidepressants, mood stabilizers, neuroleptics, and tricyclic antidepressants to not taking 
these medications and found no significant associations with compliance (Ghaziuddin et 
al., 1999). When adherence to antipsychotics was compared to adherence to mood 
stabilizers and anticonvulsants no association was found. Nor was an association found 
between olanzapine, quetiapine, and risperidone (Patel et al., 2005). Pogge et al. also did 
not find differences in adherence for those prescribed olanzapine compared to risperidone 
(Pogge et al., 2005). 
 
24 
 
Summary 
Therapy-related factors can only be investigated if the definition of adherence occurs 
after therapy has taken place and if the therapy was systematically recorded and was 
fairly constant throughout treatment. Perhaps these limitations explain the lack of studies 
investigating side effects despite findings that patients justify discontinuing medication 
because of side effects (Ghaziuddin et al., 1999; Moses, 2011). The findings on 
medication types are mixed. As previously mentioned, there were several types of 
medications investigated for several diagnoses and this heterogeneity may explain the 
lack of consistent findings. Studies investigating other therapy-related factors such as 
frequent changes in treatment and immediacy of beneficial effects were not found in this 
literature search. 
2.5.3.6 Summary 
In the literature, engagement, adherence, and compliance are overlapping concepts that 
are often considered synonymous. Even when the same term is used, definitions and 
measurements vary. Due to the similarities amongst the concepts, varying definitions, and 
varying measures, we have interpreted the literature holistically, summarizing the 
predictors and the strength and directions of associations. 
 As discussed earlier, the definition of engagement in this thesis is most closely 
aligned with that of Mowbray et al., in which engagement is “the first stage which must 
be completed before clients can successfully move into the stages that follow: persuasion, 
active treatment and relapse prevention” (Mowbray et al., 1993, p. 338). Engagement is 
the first step towards acceptance of treatment, formation of a therapeutic alliance, and 
adherence to therapy. We will use attendance at the initial clinical appointment, given 
that youth were previously screened and deemed eligible for such an appointment, as an 
indicator of engagement in FEMAP treatment. We recognize that attendance is only a 
proxy for engagement in treatment. O’Brien et al. suggest that “whilst physical presence 
or attendance is necessary, engagement is a more complex phenomenon encompassing 
factors that include acceptance of a need for help, the formation of a therapeutic alliance 
with professionals, satisfaction with the help already received and a mutual acceptance 
and working towards shared goals” (O’Brien et al., 2009, p. 559). Although attendance is 
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not sufficient for engagement, it is a valid measure, because it is a necessary condition of 
engagement.  
 We have found that engagement research largely focuses on the patient-related 
and social and economics dimensions. Demographic variables such as ethnicity and 
socioeconomic status are frequently investigated in adherence studies.  
We found that system-wide factors are rarely investigated. This is likely because, health 
care team and system-related factors can only be investigated where there is variation in 
those factors. This would require multi-center studies so that these factors could be varied 
systematically. We also found that for single-center studies, authors rarely provided 
details of relevant system-wide factors, such as the cost of therapy and coverage levels.  
 We found little consensus on the strength and direction of any of those 
associations (patient-related, social and economic). The reason for variation in the 
literature is unclear. It is possible that these factors are not associated with engagement 
and studies find varying results by chance. However, the studies differed in terms of 
sample size, treatment setting, and region. Study sample size ranged widely from 32 
people to 3,681 people. For cohort studies, the samples sizes ranged from 32 to 352 
people (Baruch et al., 1998; Coletti et al., 2005; de Haan et al., 2015; DelBello et al., 
2007; Ghaziuddin et al., 1999; Granboulan et al., 2001; King et al., 1997; Laurier et al., 
2010; Moses, 2011; Munson et al., 2010; Patel et al., 2005; Pelkonen et al., 2000; Pogge 
et al., 2005; Timlin et al., 2014) while the two cross-sectional studies included 1,650 
people and 3,681 people (Fontanella et al., 2011; Stewart & Baiden, 2013). The majority 
(9) of studies were conducted in the U.S., two in Canada, two in Finland, and one from 
each of the UK, The Netherlands, and France. Health system factors undoubtedly vary 
widely by country; however, health system factors were not reported in each study. 
Furthermore, the treatment settings included two community-based settings (Baruch et 
al., 1998; de Haan et al., 2015), one psychiatric in-patient setting (Timlin et al., 2014), 
one youth care center (Laurier et al., 2010), one adult mental health facility (Stewart & 
Baiden, 2013), and one study investigated intensive care management though the 
description of the setting is incomplete (Moses, 2011). Several studies recruited patients 
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who had been admitted to hospital though none clarified how much of the treatment took 
place in hospital and post-discharge (DelBello et al., 2007; Ghaziuddin et al., 1999; 
Granboulan et al., 2001; King et al., 1997; Patel et al., 2005; Pogge et al., 2005). One of 
the population-based studies did not include the treatment setting other than to say in- and 
out-patients were included (Fontanella et al., 2011). The remaining studies included only 
outpatients but the setting (hospital, doctor’s office, community or other) was not 
described (Coletti et al., 2005; Munson et al., 2010; Pelkonen et al., 2000). 
Even with the literature search limited to youths receiving treatment for mood and 
anxiety disorders, the study populations differed in potentially important characteristics 
which may have influenced findings. Most of the studies included patients aged 12 to 18 
years with the exception of Baruch et al. who included ages 12 to 24 years, Coletti et al. 
included patients from ages 12 to 19 years, De Haan et al. who included patients aged 12 
to 20 years, and Pelkonen et al. who included patients aged 12 to 22 years (Baruch et al., 
1998; Coletti et al., 2005; de Haan et al., 2015; Pelkonen et al., 2000). Despite knowledge 
that developmental and social changes continue to occur well into the 20s, few studies 
included participants in their 20s. Although only mood and anxiety disorders were 
included there was still variation amongst the diagnoses of the study populations. Two 
studies included only patients with a depressive disorder (Fontanella et al., 2011; Munson 
et al., 2010), three included only patients with a diagnosis of bipolar disorder (Coletti et 
al., 2005; DelBello et al., 2007; Patel et al., 2005), two specified patients with suicidality 
(Granboulan et al., 2001; King et al., 1997), and the remainder either did not specify the 
diagnoses or included several diagnoses.  
The lack of Canadian studies is evident from the literature review, as is the 
paucity of data on youth engagement to mood and anxiety disorders treatment in 
community-based settings. 
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Chapter 3  
3 Methods 
This study was a secondary analysis of data collected from the First Episode Mood and 
Anxiety Program (FEMAP). Ethics approval was obtained from the Research Ethics 
Board (REB) of Western University for all FEMAP research projects resulting from the 
collection of data. Pre-specified factors were investigated for their association with 
engagement in FEMAP.  
3.1 First Episode Mood and Anxiety Program 
FEMAP is a community-based program in London, Ontario. FEMAP was founded by Dr. 
Elizabeth Osuch in 2006 in response to the lack of mental health services available to 
youths. “Adolescent mental health is everybody’s business and nobody’s responsibility” 
(World Health Organization, 2012, p. 20). This quote encapsulates the state of adolescent 
mental health in the World Health Organization’s review of international organizations’ 
initiatives for adolescent mental health between 2000 and 2010. Since 2006, FEMAP has 
grown to include four psychiatrists, one clinical psychologist, one addictions counsellor, 
three research staff, and two administrative staff, some of whom are full-time and the 
remainder are part-time. 
 During FEMAP’s infancy, outreach was conducted by collaborating with nearby 
educational institutes including Fanshawe College, the Thames Valley District School 
Board, the London District Catholic School Board, and the Student Development Centre 
and Student Health Services at the University of Western Ontario. This was done to make 
health professionals and potential patients aware of the services offered by FEMAP. 
FEMAP also worked to reach potential patients by creating a website and pamphlets 
containing information about mood and anxiety disorders and FEMAP’s services. 
FEMAP relocated to a renovated house in the community in 2009, providing a less 
stigmatizing environment (Osuch, Vingilis, Fisman, & Summerhurst, 2016). Previously, 
FEMAP had been located at University Hospital in London, Ontario. It was thought that 
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the new community-based, youth-friendly setting would encourage engagement in the 
program.  
3.1.1 FEMAP Eligibility Criteria 
FEMAP treats patients aged 16 to 25 years with a suspected or diagnosed mood and/or 
anxiety disorder. Individuals currently involved with the criminal justice system, those 
with a major medical illness such as multiple sclerosis or uncontrolled diabetes, 
significant learning disability, or primary substance abuse problem are excluded from 
enrollment. Additionally, individuals who have had lifetime medication treatment 
amounting to more than 18 months are not eligible for treatment in FEMAP. 
 
Figure 3.1 FEMAP Pathway  
The pathway through care at FEMAP typically begins with a phone call. (See 
Figure 3.1). Youth, their parent, physician or another health care professional make the 
initial contact with FEMAP, but ultimately, the FEMAP staff member conducts the pre-
intake screening with the youth him/herself. A trained interviewer conducts the pre-intake 
telephone screening consisting of five-questions and assesses the inclusion and exclusion 
criteria discussed previously. A licensed clinical social worker then conducts the intake 
appointment to evaluate the specific needs of the youth, their level of symptom severity 
and immediacy of need for care, as well as the ways in which symptoms are affecting the 
youth’s life.  
Reassured 
Pre-intake 
Telephone 
Screening 
(T-1) 
Intake 
Appointment 
(T0) 
Accepted 
(N=366) 
Referred 
Clinical 
Appointment 
(T1) 
Attends Clinical 
Appointment 
Does Not Attend 
Clinical 
Appointment 
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 Following the intake appointment, a case conference is held with a minimum of 
two licensed clinicians to determine the best course of action. The youth may be accepted 
into FEMAP, referred to a more appropriate service, or in rare instances when specialist 
healthcare services are deemed unnecessary, youth are reassured that no further care is 
required. Youth are provided with a list of resources and crisis center phone numbers. 
More recently, as the waiting list for treatment has become longer, some have been 
provided with recommendations for alternative treatment, such as going to their family 
doctor, or seeing a psychologist. This option has been reserved for straightforward cases 
in which no treatment has been previously tried. Other options include contacting the 
Sexual Assault Center of London, the Prevention and Early Intervention Program for 
Psychoses, or others. For those accepted into FEMAP, a clinical appointment is 
scheduled in person or by phone or text. A social worker makes three attempts, each 
separated by approximately one week, to contact the individual to schedule a clinical 
appointment. Not all youth accepted into FEMAP engage in treatment by attending the 
clinical appointment.  
3.1.2 Previous FEMAP Research 
FEMAP has treated well over 1,000 patients since it began operating in 2006. Through 
the years, several small projects and larger grant-funded research projects have facilitated 
data collection to allow for appraising the effectiveness of the program. FEMAP 
researchers were twice awarded funding from the Academic Medical Organization of 
Southwestern Ontario (AMOSO) Innovation fund in both 2009 and 2013, hereafter called 
Innovation I and Innovation II. FEMAP is funded solely by research grants thus all 
patients in Innovation II partake as research participants. Innovation II study data will be 
the subject of this thesis; however, findings from previous research on Innovation I are 
important to understand the FEMAP population and effectiveness of the program. 
3.1.2.1 Innovation I 
FEMAP previously conducted a formative evaluation of its mental healthcare delivery 
model to assess whether the program was reaching the target audience and properly 
implementing intake and assessment processes (Ross, Vingilis, & Osuch, 2012). Ninety-
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three participants who arrived at FEMAP during a 12-month period from 2009 to 2010 
provided information for that evaluation. Demographic characteristics of the initial 
population showed that 32% were male, 82% Caucasian, and 71% reported some 
previous mental health care. FEMAP patients were experiencing significant 
symptomology. Thirty-nine percent of participants presented with combined depression 
and anxiety symptoms, 28% indicated primarily depression symptoms, 16% indicated 
primarily anxiety symptoms, 9% bipolar symptoms, 7% post-traumatic stress disorder 
symptoms, and 2% alternative or indeterminate diagnosis. Furthermore, the participants 
were experiencing significantly impaired functioning, missing an average of 2.6 days of 
school or work per week, and functioning at reduced levels for 4.2 days of the week. 
Eighty-one percent of patients presented with moderate to severe depressive symptoms 
and 95% presented with high levels of trait anxiety indicating that the outreach was 
successful in targeting youths in need of specialty services. Preliminary evaluations of 
FEMAP demonstrated patients’ significant improvements in school, work, and social 
functioning (Ross et al., 2012).  
 An additional process evaluation was conducted to again ascertain whether 
FEMAP was reaching the target population and achieving the desired health outcomes 
(Osuch et al., 2015). A total of 548 youths arriving at FEMAP between October 2009 and 
November 2012 consented to participate in the research. Of the 548 youths in the 
Innovation I cohort, 399 were treated at FEMAP and the remaining 149 were referred to 
alternative sources of care or, rarely, were reassured only. The treated population was 
61% female, 60% arrived without a physician’s referral, and 63% had received prior 
treatment. The breakdown of diagnostic categories was 34% diagnosed with depression 
and anxiety, 30% diagnosed with a depressive disorder, 16% diagnosed with an anxiety 
disorder, 10% diagnosed with a bipolar disorder, and remaining diagnoses each 
comprised less than 5% of the population. 
 On this previous cohort of patients, FEMAP researchers examined predictors of 
follow-through for both patients accepted to FEMAP and those who were reassured or 
referred. Individuals were contacted at least three months following the pre-intake 
assessment and asked whether they followed-through with their recommended treatment. 
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Those who answered affirmatively were considered to have followed through. 
Researchers investigated the association between gender, presumptive diagnosis at 
intake, lifetime marijuana use, physician referral or no physician referral, accepted versus 
referred or reassured, parental marital status, the Adult Attention Deficit and 
Hyperactivity Disorder Self-Report Scale score, and Emotion Regulation Questionnaire 
score on loss to follow-up. Logistic regression analysis indicated lifetime use of 
marijuana and having unmarried and non-cohabitating parents was associated with loss to 
follow-up, whereas contacting FEMAP through a route independent of a physical referral 
was protective against loss to follow-up (Osuch et al., 2015).  
3.1.3 Innovation II 
Innovation II is a more recent cohort of FEMAP patients recruited between May 2013 
and July 2015. Innovation II differs from Innovation I in that only patients accepted to 
FEMAP provided follow-up data, but also in the process of delivering care, FEMAP 
collected information on patients. The wait time between being accepted into FEMAP 
and having a clinical appointment with a physician varied from 5 to 446 days with a 
median wait time of 44.5 days. For Innovation I follow-up, all patients who presented to 
FEMAP were contacted, including those who were referred to other services, but not for 
Innovation II. In Innovation II, follow-up was conducted only on patients offered 
treatment. Additionally, questionnaires provided to the Innovation II cohort differ from 
those previously used. Notably, Innovation II included a trauma history questionnaire, a 
patient satisfaction questionnaire and the Inventory of College Students’ Recent Life 
Experiences questionnaire to allow investigation of these factors as predictors of 
treatment outcomes.  
3.1.3.1 Data Collection 
Innovation II used a structured interview protocol for intake and follow-up procedures. 
(See Figure 3.1). Data collection for research occurs during the initial brief phone-
screening interview, at pre-intake (T-1), at intake (T0), at the clinical evaluation (T1), 
two months after clinical evaluation (T2), and four months after the clinical evaluation 
(T3). (See Table 3.1). Participants are asked to complete surveys in person or online 
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using fillable portable document format (PDF) forms, at different time points (See table 
3.1.). The pre-intake questionnaires are generally filled out online using fillable PDF 
forms, though some participants choose to fill them out on computers at FEMAP.  
Table 3.1 FEMAP Innovation II Data Collection Schedule 
Questionnaire 
Pre-intake 
Screening 
T-1 
Intake 
Appointment 
T0 
Clinical 
Appointment 
T1 
2 Months 
T2 
4 Months 
T3 
Demographics Survey X* Xt    
Inventory of College Students’ Recent 
Life Experiences (ICSRLE) 
 X    
Trauma History Questionnaire (THQ)  X    
Anxiety Sensitivity Index – Revised 36 
(ASI-R) 
X X X X X 
Montgomery-Åsberg Depression Rating 
Scale – Self Report (MADRS-S) 
X X X X X 
Adolescent Alcohol and Drug 
Involvement Scale – Self Report 
(AADIS) 
 X    
Short-Form Patient Satisfaction 
Questionnaire (PSQ) 
X* Xt    
Sheehan Disability Scale (SDS) X X X X X 
*Prefix ‘20’ participants only      
tPrefix ‘22’ participants only      
 FEMAP participant identifications were prefixed with either a “20” or “22”. The 
only difference between the two groups of patients was the timing of the questionnaires 
clarified below. Data on predictors of engagement was taken from the intake (T0) 
collection time, with the exception of the group of patients with the “22” prefix, for 
whom the demographic questionnaire and Patient Satisfaction Questionnaire (PSQ) were 
only available for the pre-intake (T-1) time point. Data on engagement in therapy was 
taken from clinical records on whether or not the patient attended the clinical 
appointment (T1). The “20” and “22” participants were otherwise identified and treated 
identically. 
3.2 Current Research Study 
Mental health conditions are prevalent among youth. FEMAP offers therapy tailored to 
youth, based in a community setting with no requirement for physician referral. The goal 
of the study was to contribute to understanding of the factors that influence engagement 
of youth in mood and anxiety disorders treatment, specific to a community-based 
treatment center in Canada 
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3.2.1 Research Objectives 
The research aims are as follows: 
1. To calculate the proportion of patients who engaged in FEMAP of those who 
were offered treatment at FEMAP. 
2. To investigate the predictors of engagement in treatment.  
3.2.2 Population 
Youths with suspected or diagnosed mood or anxiety disorder, meeting FEMAP’s 
treatment criteria make up the study sample. Between May 2013 and July 2015, 400 
patients completed the intake process for FEMAP and were either accepted, referred, or 
reassured only. Of the 400 patients, 366 were accepted into FEMAP and make up the 
study sample. 
3.2.3 Variables 
3.2.3.1 Outcome Variable 
The thesis is focused on predictors of engagement in therapy for those offered treatment 
at FEMAP. Much of the research has focused on adherence to treatment amongst youth, 
whereas little research has investigated engagement in treatment. As noted in chapter 2, 
adherence and engagement have often been used interchangeably in the literature, and 
similar factors that distinguish those who adhere to treatment from those who do not also 
distinguish individuals who engage in treatment from those who do not. Our definition of 
engagement is aligned with that of Mowbray et al., in which engagement is “the first 
stage which must be completed before clients can successfully move into the stages that 
follow: persuasion, active treatment and relapse prevention” (Mowbray et al., 1993, p. 
338).  
 This study will compare individuals who were accepted into FEMAP and engaged 
in the program to those who were accepted to the program but did not engage. Individuals 
who arrived for their clinical appointment will be considered engaged in therapy. 
Individuals offered treatment at FEMAP who did not attend a clinical appointment, 
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despite attempts to schedule or reschedule an appointment, will be considered not to have 
engaged in therapy.  
3.2.3.2 Explanatory Variables 
Innovation II data collection allows for investigating the impact of several variables as 
predictors of engagement. These variables include age, gender, ethno-racial background, 
parental marital status, parental socioeconomic status as indicated by parental education 
level, quantity of alcohol use per occasion, tobacco use, marijuana use, other illicit drug 
use, self-referral, severity of illness, and functioning. FEMAP data also allow for 
investigating the impact of additional variables that have not been investigated previously 
in relationship to adherence or engagement amongst youth. The additional variables 
include trauma history, satisfaction with previous mental health care, and daily hassles. 
Age 
FEMAP inclusion criteria required a participant’s age to be within 16 to 25 years. 
Patients were asked for their age in years in the demographics questionnaire. For the 
analysis, age was categorized into ages 16 to 18 and ages 19 to 25. These categories 
reflect the groupings used to distinguish adolescent and adult studies in the literature. 
(See Appendix A.) 
Gender 
Within the demographics questionnaire, participants were asked to indicate their sex. The 
options presented were male or female. Although the demographics questionnaire asked 
for the participant’s sex we use the term gender because we expect gender and sex were 
100% correlated in the study sample and it is gender that has been investigated for 
association with engagement in previous studies. As well, the mechanism for the 
association is likely socio-cultural rather than biological. 
Ethno-racial Background 
FEMAP collected individuals’ ethno-racial backgrounds in the demographics 
questionnaire. Multiple responses were encouraged as patients were instructed to, “please 
check all that apply”. Response options included Aboriginal (First Nations, Metis, or 
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Inuit), Latin American (e.g. Argentina, Mexico Nicaragua), East Asian (China, Japan, 
Korea, Taiwan), Indo-Caribbean (Guyanese with origins in India), South Asian (India, 
Sri Lanka, Pakistan), Middle Eastern (Egypt, Iran, Israel, Saudi Arabia), South East 
Asian (Vietnam, Malaysia, Philippines), White Canadian or White American, White 
European (England, Greece, Sweden, Russia), Black Canadian or African American, or 
Black African (Ghana, Kenya, Somalia).  
 The majority of FEMAP’s population selected White Canadian or White 
American or White European and not any other category. Due to the limited sample size 
of the remaining categories, the ethno-racial variable was recoded into a binary variable. 
(See Appendix B.) Individuals who selected only White Canadian or White American or 
White European were grouped together into a “white ethno-racial background” category 
and anyone who selected anything else was grouped into an “other ethno-racial 
background” category. The other ethno-racial background category included those who 
selected mixed ethno-racial backgrounds including those who selected White Canadian or 
White American or White European and another ethno-racial category. 
Socioeconomic Status as indicated by Parents’ Education Level 
On the demographics questionnaire administered at intake, FEMAP provided seven 
possible responses for parent’s level of education: less than seventh grade, junior high 
school (9th grade), partial high school (10th or 11th grade), high school graduate, partial 
college, standard college or university graduation and graduate professional training. 
FEMAP asked the participants to respond for each of their parents.  
 For analyses, the responses were recoded to obtain the highest level of education 
of either parent, consistent with the variable household level of education from the 
Canadian Community Health Survey (Statistics Canada, 2014). The categories were 
combined and dichotomized due to the limited sample size. Using the upper cut-off used 
by De Haan et al., the variable was dichotomized into those with at least one parent 
having a college or university degree and those with neither parent having a college or 
university degree. (See Appendix C.) 
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Parents’ Marital Status 
The demographics questionnaire asked “What best describes your parents?” and the 
options were married, separated, divorced, widowed, and common law/unmarried living 
together. These categories were regrouped into two groups: married (married and 
common law/unmarried, living together and unmarried) and unmarried (separated, 
divorced, and widowed). (See Appendix D.) These groupings reflect those used in 
FEMAP’s previous publication (Osuch et al., 2015). 
Substance Use 
The Adolescent Alcohol and Drug Involvement Scale – Self-Report (AADIS) is a 
research and screening tool for adolescent alcohol and drug use. Part A of the survey asks 
about pattern of use for 13 substances with eight response levels, “never used”, “tried but 
quit”, “several times a year”, “several times a month”, “weekends only”, “several times a 
week”, “daily”, and “several times a day”. Part B of the survey contains 14 multiple 
choice questions about usage that are scored using weights. Higher scores represent 
higher levels of alcohol and drug involvement. The AADIS is intended to be used as a 
research instrument and/or screening tool and has not been validated for diagnosis, 
although a score of greater than or equal to 37 merits further assessment for substance use 
disorder (Moberg, 2005). 
 FEMAP researchers modified the original questionnaire. In part B, responses to 
questions about alcohol and drug use were separated to obtain more detailed information. 
As a result, it is not possible to apply the available scoring weights to the questionnaire 
data in order to calculate an AADIS score.  
At intake, FEMAP collected information about substance use, including drugs and 
alcohol, using the AADIS. 
Marijuana Use 
We used question 3 of part A of the AADIS which asked participants to select their 
“marijuana or hashish (weed, grass, blunts)” use on an eight-item scale from never to 
several times a day. For analyses, the responses were dichotomized into never used 
versus any use ever. The first response option after “never used” was “tried but quit”. 
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This response option is somewhat ambiguous because the term “quit” may imply a habit 
was formed that required quitting. The response groups individuals who used the 
substance on one occasion with those who were former potentially frequent users. The 
grouping used reflects the potential mechanism of a rejection of authority or medical 
advice (Pogge et al., 2005).  (See Appendix E.) 
Other Illicit Drug Use 
Questions 4 through 13 of the AADIS part A asked about illicit drug use other than 
marijuana such as LSD, ecstasy, cocaine, and others. Participants answered on an eight-
point scale from never used to several times a day. The results were combined and 
dichotomized into never used any illicit drugs other than marijuana versus any illicit drug 
use other than marijuana. The grouping is the same as that utilized for marijuana use. 
(See Appendix F.) 
Tobacco Use 
We used question 1 of part A of the AADIS which asked participants to select their 
“smoking tobacco (cigarettes, cigars)” use on a scale with eight response options from 
never used to several times a day. For analyses, the responses were dichotomized into 
never used versus any use ever consistent with the other substance use variables. (See 
Appendix G.) 
Quantity of Alcohol Consumed per Occasion 
Alcohol use was captured by a few questions of the AADIS. Alcohol use history was 
reported in part A with the same response options as the previous substance use 
questions. Part B contains 14 questions about usage including frequency, type of alcohol 
consumed, with whom it is consumed, how the alcohol is obtained, and amount typically 
consumed per occasion. Question 9 in Part B of the AADIS was used to determine the 
quantity of alcohol consumed per occasion. The question asked, “When you drink 
alcohol, how much do you usually drink?” The response options were 1 drink, 2 drinks, 
3-4 drinks, 5-9 drinks, and 10 or more drinks. For analyses, the results were dichotomized 
into 4 drinks or fewer and 5 drinks or more. (See Appendix H.) This questions was 
selected amongst the many options because the variable is consistent with the Drug Use 
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Among Ontario Students definition of binge drinking (Boak, Hamilton, Adlaf, & Mann, 
2015). Binge drinking is defined by the Public Health Agency of Canada as five or more 
drinks per occasion for males and four or more for females (Public Health Agency of 
Canada, 2016).  
Satisfaction with Previous Mental Health Care 
The Short-Form Patient Satisfaction Questionnaire (PSQ) is a tool developed by the 
RAND Corporation to assess seven dimensions of patient satisfaction with general health 
care practitioners. It correlates well with the 50-item patient satisfaction questionnaire 
from which it was derived (Marshall & Hays, 1994). Patients answer 18 questions 
regarding their satisfaction with medical care they have received using five-point Likert 
scales. The PSQ scoring algorithm provides summary scores for each of the seven 
dimensions.  
 For Innovation II, FEMAP researchers administered the PSQ during the pre-
intake appointment for “22” patients and during the intake appointment for “20” patients. 
FEMAP researchers made several modifications to the original questionnaire. In the 
original questionnaire, part A contained questions about the frequency of using different 
general practitioner services and part B included 18 items on patient satisfaction with 
general practice. FEMAP researchers removed items 1, 2, 5, 7, 9, and 18, and changed 
the wording on the remaining 12 items to reflect mental health care in Canada.  
Due to the changes made to the PSQ, the scoring for the PSQ cannot be retrieved. 
Thus patient’s satisfaction with previous mental health services was measured using a 
single item from the questionnaire, the statement, “The mental health care I have received 
has been just about perfect.” This is similar to the measurement used in a 2003 study 
investigating the relationship between satisfaction and quality of mental healthcare 
(Edlund, Young, Kung, Sherbourne, & Wells, 2003). The five response options were 
categorized into three groups: 1) not applicable, 2) satisfied (agreed or strongly agreed), 
and 3) dissatisfied (uncertain, disagreed, or strongly disagreed). (See Appendix I). 
It was assumed that those who responded not applicable did so because they had 
never received mental health services. To investigate whether this was indeed the case a 
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subset of mental health care services listed in part A, psychiatric unit in hospital, 
outpatient hospital mental health service, private mental health professional, and 
community mental health services, were chosen as services whose use would be solely 
for mental health services in comparison to others (e.g. family doctor, high school 
guidance counselor) which could be accessed for other needs. Investigations showed that 
only four of the 56 participants reporting that the question about satisfaction with overall 
mental health care was not applicable had used one of the services listed above.  
Self-Referral 
FEMAP maintains records on how patients were referred to the program. The referral 
categories were non-traditional referral (e.g. self-referral, parent referral, post-secondary 
school services) based on responses to the pre-intake telephone screening interview or 
physician referred based on FEMAP’s receipt of a physician referral. 
Trauma History 
The literature review did not reveal any previous studies on the association between 
trauma history and adherence. FEMAP; however, collected trauma history using the 
Trauma History Questionnaire (THQ). A link between trauma and adherence has not 
been established but it is possible that having experienced trauma may affect how patient-
provider relationships are formed and therefore affects engagement. The THQ was 
developed to collect information on past exposure to events that could be traumatic and 
lead to development of post-traumatic stress disorder (PTSD) (Hooper, Stockton, 
Krupnick, & Green, 2011). The questionnaire has been successfully implemented across 
a variety of populations with differing trauma histories (e.g. residents of battered 
women’s shelter, police officers, Holocaust survivors, adult survivors of childhood 
trauma and abuse, and people with life-threatening illnesses). The THQ was developed to 
measure traumatic events in an adult population, as classified by the Diagnostic and 
Statistical Manual of Mental Disorders. The questions focus on three domains of trauma: 
1) crime-related events, 2) general disaster and trauma, and 3) unwanted physical and 
sexual experiences.  
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 FEMAP measured trauma experience by administering the THQ at intake (T0). 
FEMAP adapted the THQ for use in the youth population by changing the wording of 
some of the questions. FEMAP also changed the response options to “Never”, “Before 
age 16”, “Between age 16 and 1 year ago” and “Within past year”, for items 1 to 18 only. 
Questions 19 to 24 were altered to ask only whether or not the event occurred. On the 
original questionnaire the responses ask for whether the event occurred, the number of 
times, and approximate age(s).  
There is no official scoring method for the THQ (Hooper et al., 2011); however, 
researchers have commonly counted the different types of trauma. Because of the 
changes to the THQ, the number of times a traumatic event occurred cannot be identified. 
The options “Never”, “Before age 16”, “Between age 16 and 1 year ago”, and “Within 
past year” are not mutually exclusive. For example, a 17-year-old participant having 
experienced a traumatic event during the past year could select “Between age 16 and 1 
year ago” and “Within past year” for the same event. Instead we used the method of 
Spertus et al., in which the total number of types of trauma experienced were calculated, 
and range between 0 (no trauma experienced) and 3 types (at least one of each type of 
trauma: crime-related, general disaster and trauma, and unwanted physical and sexual 
experiences, experienced). This range was then divided into low trauma (0 or 1 types) 
and high trauma (2 or 3 types) (Spertus, Burns, Glenn, Lofland, & Lance McCracken, 
1999). (See Appendix J.) 
Inventory of College Students’ Recent Life Experiences (ICSRLE) 
Daily hassles were not measured by previous studies; however, it is available in this 
dataset and may be associated with adherence. Daily hassles may be a patient-related 
factor measuring barriers to treatment that affect engagement. Alternatively, it may be 
associated with motivation for treatment and be associated with engagement through that 
pathway. The Inventory of College Students’ Recent Life Experience (ICSRLE) is a 
measure of daily hassles developed using a Canadian student population (Kohn, 
Lafreniere, & Gurevich, 1990). The scale measures a construct called “hassles”. The 
ICSRLE contains 49 questions about daily hassles that a college student may have 
experienced. Individuals rate the intensity of the experience for each item over the past 
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month on a scale from 1 (not at all part of my life) to 4 (very much part of my life). 
Previous studies have used the ICSRLE with good internal consistency (Bodenhorn, 
2007; Kohn et al., 1990; Osman, Barrios, Longnecker, & Osman, 1994). The alpha 
coefficient was 0.88 when completed by Canadian undergraduate students(Kohn et al., 
1990). When completed by undergraduate students attending an American university the 
alpha coefficient was 0.92 (Osman et al., 1994). Thirty-seven of the items are used for the 
following subscales: developmental challenge, time pressure, academic alienation, 
romantic problems, assorted annoyances, general social mistreatment, and friendship 
problems. Higher scores indicate more frequent problems. 
 FEMAP researchers modified the questionnaire to better suit their 
population, which includes high school students and employed youth not in school. 
Where questions made reference to academics, FEMAP included terms for work as well. 
Additionally, the question about conflict with teaching assistants and the question about 
interruptions of school work were removed. Thus the total score, obtained by summing 
the items, ranges from 47 to 188 rather than 49 to 196.  We used the modified ICSRLE as 
a measure of hassles where higher scores indicate more hassle.  
Severity of Illness – Depression  
The Montgomery – Åsberg Depression Rating Scale (MADRS-S) is a self-rated 
depression scale used to assess the presence and severity of a depressive episode. The 
level of distress for each of nine items is scored from 0 (none at all) to 3 (maximum). The 
sum of the scores on the nine items provides an overall score where higher scores 
indicate higher levels of depression. Cut-off values for remission have been established 
by previous studies and suggest using a value of less than or equal to 10 (Cunningham, 
Wernroth, Von Knorring, Berglund, & Ekselius, 2011; Hawley, Gale, & Sivakumaran, 
2002; Riedel et al., 2010; Zimmerman, Posternak, & Chelminski, 2004). 
We incorporated the total score on the MADRS-S into our analyses, with higher 
scores indicating more depressive symptoms. Two previous studies have calculated 
Cronbach’s alpha as 0.84 in adult populations diagnosed with MDD (Cunningham et al., 
2011; Fantino & Moore, 2009).  
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Severity of Illness – Anxiety 
The Anxiety Sensitivity Index – Revised (ASI-R) is a survey that measures anxiety 
sensitivity, which is the fear of anxiety-related sensations (Taylor & Cox, 1998). Thirty-
six items about different forms of anxiety and anxiety-provoking scenarios are rated from 
0 (very little) to 4 (very much). The score from each item is summed to obtain a total 
score ranging from 0 to 144, where a higher score indicates higher levels of anxiety 
sensitivity. There are six sub-scales: 1) fear of cardiovascular symptoms, 2) fear of 
respiratory symptoms, 3) fear of gastrointestinal symptoms, 4) fear of publicly observable 
anxiety reactions, 5) fear of dissociative and neurological symptoms, and 6) fear of 
cognitive dyscontrol, each of which had moderately large correlation with the Beck 
Anxiety Inventory (Taylor & Cox, 1998).The total score, ranging from 0 to 144, on the 
ASI-R was used for analyses, with higher scores indicating greater anxiety sensitivity. 
Excellent internal consistency (α=0.95) was found in a sample of undergraduate students 
(Arnau, Broman-Fulks, Green, & Berman, 2009) as well as a sample of patients with 
diagnosed anxiety disorders (Deacon & Abramowitz, 2006).  
Functioning 
The Sheehan Disability Scale (SDS) is a 5-item questionnaire used to assess functional 
impairment. The first three questions ask the individual to score the extent to which their 
symptoms have disrupted work or school, social, and family life from 0 (not at all) to 10 
(extremely). Respondents can skip the first question and select “I have not worked or 
been in school”. These scores can be analyzed individually or can be summed to provide 
an overall score ranging from 0 to 30. Questions four and five inquire about lost 
productivity but do not form part of the scoring procedure (Leon, Shear, Portera, & 
Klerman, 1992). 
The SDS was used to measure functioning, with higher scores indicating greater 
disability. In the absence of specific guidelines for scoring the first question with the 
option “I have not worked or been in school”, the average of the remaining two items 
were used to obtain a total score. (See section 3.3.2.1 for further details.) 
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3.3 Statistical Analysis 
All statistical analyses were conducted using SAS software version 9.4 (“SAS,” 2013). 
Descriptive statistics were calculated for the explanatory variables and are described as 
mean (standard deviation) in the case of continuous variables and as proportions for 
categorical variables.  
3.3.1 Univariate Analysis 
Each variable was individually investigated for association with the outcome, 
engagement in FEMAP. Chi square tests were performed for categorical variables with 
all cell counts greater than five and Fisher’s Exact test used for those with an expected 
cell count of less than five. T-tests were performed for continuous factors. Associations at 
the α=0.05 significance level were flagged. 
3.3.2 Missing Data 
In any data collection we expect to have missing values. Missing values can occur for a 
multitude of reasons such as computer error, responder fatigue, or refusal to answer 
specific questions.  
 Data can be classified as missing completely at random (MCAR), missing at 
random (MAR), or missing not at random (MNAR). MAR occurs when the distribution 
of missing values does not depend on the value of missing data but may depend on the 
observed data. MCAR depends on neither observed nor missing data. MNAR occurs 
when the distribution of missing values depend on the missing value (Schafer & Graham, 
2002). We describe our approach to missing questionnaire items and missing study data 
in the sections that follow. 
3.3.2.1 Missing Questionnaire Items 
Missing responses to questionnaire items on the Anxiety Sensitivity Index (ASI-R), 
Montgomery-Åsberg Depression Rating Scale (MADRS-S), Sheehan Disability Scale 
(SDS), and Inventory of College Students’ Recent Life Experiences (ICSRLE) were 
imputed using person mean substitution. Person mean substitution is a method of 
imputation that takes the mean of each participants’ non-missing responses and 
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substitutes that value for missing values. The underlying assumption is that the missing 
items would have had the same score as the mean of the non-missing items. In contrast to 
item mean substitution which imputes the mean value of the other respondents for a 
missing question, the method of person mean substitution has been shown in simulation 
studies to perform well in questionnaires consisting of several similarly scaled items (Gil 
& Kromrey, 2013; Hawthorne & Elliott, 2005; Shrive, Stuart, Quan, & Ghali, 2006).  
 
 Each measure meets the assumptions required for the person mean substitution 
method to be optimal; the item responses are scored on the same scale, each question 
contributes equally to the overall score, and all questions measure a single construct. On 
the ASI-R, each of the 36 items is scaled from 0 to 4 and summed to calculate an overall 
score. Similarly, the MADRS-S has nine items, each scaled from 0 to 3 and summed to 
provide an overall score. The SDS has three items each scaled from 0 to 10 and summed, 
and the ICSRLE has 47 summed items each scaled from 1 to 4. Each of the questions on 
the ASI-R, MADRS-S, SDS, and ICSRLE measure the underlying construct of the 
questionnaire (Downey & King, 1998; Fayers, Curran, & Machin, 1998; Leon et al., 
1992).  
 
 For the Trauma History Questionnaire (THQ), we performed logical imputation. 
Twenty-four potentially traumatic events are listed, and for each event there are four 
check-boxes: “Never”, “Before age 16”, “Between age 16 and 1 year ago”, and “Within 
past year”. If the event occurred the respondent should leave “Never” blank and use the 
other boxes to indicate the timing of the event. To indicate that a particular event was 
never experienced the respondent should check the box indicating “Never” and leave the 
other three options blank. If a participant left all of the boxes unchecked to all items, the 
responses to all 24 items were considered missing. (This applied to three participants.) 
Other times, a participant may have answered the majority of questions and left the 
remainder of the items blank. In these cases, logical imputation was used to assign 
“Never” to the other missing items. In this instance, it was assumed that blank items were 
skipped because the event had not occurred and thus no further details were provided. A 
sensitivity analysis was performed to test the impact of this assumption. The entire 
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analysis was repeated assigning the occurrence of an event if it was left blank. It was 
noted earlier that these responses are not mutually exclusive; someone who is aged 17 
and experienced a trauma at age 16 could select “between age 16 and 1 year ago” and 
“within past year” for a single event. The number of times the event occurred was not 
factored into the trauma measure so this limitation is not expected to have caused 
problems.  
Logical imputation was used for the quantity of alcohol consumed per occasion as 
well. There were 49 missing values for the quantity of alcohol consumed; however, this 
question did not allow the participant to indicate that they do not consume alcohol. Upon 
investigation of the participants’ responses to question 1, “how often do you use 
alcohol?”, 45 of these 49 participants indicated that they never consume alcohol. For 
these participants, 4 drinks or fewer was imputed, and the remaining were left as missing 
and imputed using single imputation as described below. 
 
3.3.2.2 Missing Study Data 
In the regression analysis we avoided complete case analysis, the deletion of any 
observation that has any missing value. Complete case analysis is acceptable if the data is 
missing completely at random but has the drawback of reducing the usable sample size. 
Where possible, we conducted logical imputation when questions were redundant and the 
accurate response could be deduced. We performed single imputation for variables in 
which less than 5% of the study sample had missing values. This has the advantage of 
using all of the data but the disadvantage of also reducing variance. All of the variables 
had less than 5% missing values. 
3.3.3 Associations Among Covariates 
The associations among covariates were investigated. Pearson correlations were used to 
test associations between pairs of continuous variables. Chi-square tests were used to test 
associations between pairs of categorical variables. T-tests were used to test associations 
between pairs of continuous and categorical variables. The Pearson correlation 
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coefficient threshold value of 0.6 (or -0.6) was used as a cut-off indicating a strong 
association between continuous variables (“Correlation and regression,” 2016). 
3.3.4 Multivariable Analysis 
A logistic regression model was built to identify the factors associated with engaging in 
therapy amongst youth offered treatment at FEMAP. Innovation II data collection 
afforded the opportunity to consider a variety of risk factors, as outlined in the preceding 
sections of this chapter. The first step in fitting the regression model was selecting 
variables for inclusion. To identify potential predictors of engaging in therapy a review of 
the literature was conducted (see chapter 2). Informed by the results of the literature 
review and the results of the previous Innovation I study on loss to follow-up, a set of 
predictor variables was selected including age, gender, ethno-racial background, parental 
marital status, parental education, referral, quantity of alcohol consumed per occasion, 
tobacco use, marijuana use, other illicit drug use, severity of anxiety, severity of 
depression, and functioning. Novel variables collected by FEMAP that had not been 
investigated previously in the literature (trauma history, satisfaction, and ICSRLE) were 
also included in the predictor variables. 
 One goal of fitting a regression model is parsimony, that is, ensuring that 
variables are only included in the regression model if they are significantly associated 
with the outcome and/or confound the relationship between another variable and the 
outcome. Several methods have been proposed for choosing amongst candidate variables 
when fitting a regression model. Popular methods such as forward selection, backward 
elimination, or stepwise selection employ rules such as p-value cut-offs to perform 
variable selection. The forward selection method enters variables into a null model that 
meet an entry significance criterion while the backward elimination method begins with a 
full model and sequentially removes variables that do not contribute at a specified 
significance level. The stepwise selection method combines the previous two methods, 
allowing variables to be either included or removed with each iteration (Vittinghoff, 
Glidden, Shiboski, & McCulloch, 2012). Selection criteria based on critical p-values have 
been criticized for ignoring confounding variables. The change in estimate approach is an 
additional criterion based on the degree to which a variable confounds  the relationship 
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between another variable and the outcome in a regression model (Greenland, 1989; 
Mickey & Greenland, 1989). Purposeful selection combines p-value cut-offs and change 
in estimate to select variables for inclusion in regression models that are strongly 
associated with the outcome or confound the relationship between the outcome and 
another variable (Hosmer, Lemeshow, & Sturdivant, 2013). Purposeful selection has been 
shown to be advantageous for logistic regression models used for risk factor analysis and 
outperforms automated variable selection for sample sizes ranging from 240-600 (Bursac, 
Gauss, Williams, & Hosmer, 2008).  
3.3.4.1 Purposeful Selection Method 
1. Univariate analyses were performed on each predictor variable and those that 
were identified as associated with the outcome with a p-value of 0.25 or less were 
candidates for inclusion in the logistic regression model. A higher p-value at this 
initial stage has been shown to more reliable (Maldonado & Greenland, 1993; 
Mickey & Greenland, 1989).  
2. A multivariable model was fit containing all candidate variables identified from 
step 1. The covariate with the highest p-value was identified and compared to a 
retention p-value (0.10). If the covariate’s p-value was larger than the cut-off 
value set for retention, then it was removed and a new model fit, otherwise it 
remained in the model. The fit of the reduced model was compared to the larger 
model using the partial likelihood ratio test. 
3. The change in the coefficients between the reduced and original models was 
calculated. A 15% change in any coefficient after the removal of a covariate was 
indicative of a potential confounding effect with the variable whose coefficient 
was greatly changed by its removal. If the percent change in any coefficient 
exceeded 15% the covariate remained in the model, otherwise it was removed. 
Steps 2 and 3 were repeated until the highest p-value in the model was below the 
retention cut-off.  
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4. The original variables that were not candidates for the first model were entered 
into the model one by one to determine if they were significant factors in the 
presence of the others already in the model. The non-candidate variables were 
retained in the model if the significance test was 0.15 or below. In a simulation 
study using a sample size similar to ours, 15% change in coefficients and 0.15 
retention criteria for non-candidate variables resulted in the most accurate models 
(Bursac et al., 2008). 
5. Continuous variables remaining in the preliminary main effects model were 
examined for the assumption of linearity with the logit of the outcome. (See 
section 3.3.5.1.) 
6. We pre-specified interaction terms with gender, based on plausibility of an 
interaction between gender and another variable with respect to engagement. 
Interactions with gender that were significant at the 0.05 significance level were 
entered into the model one at a time. 
7. The model was assessed for goodness of fit, multicollinearity, and influential 
observations. (See section 3.3.5.2.) 
3.3.5 Model Fit and Diagnostics 
3.3.5.1 Assessing Linearity Assumptions of the Logistic 
Regression Model 
In order to test the relationship between continuous variables and the logit of the 
outcome, we investigated scatter plots of the mean predicted probability of the outcome 
for each value of the continuous variable on the y-axis and the continuous variable, on the 
x-axis. The scatter plots were smoothed using a local regression function and the 
resulting graph was visually inspected to ensure the relationship was linear.  
3.3.5.2 Goodness of Fit 
The goodness of fit of the model was tested using the Hosmer-Lemeshow test. The 
Hosmer-Lemeshow test calculates the observed and expected frequencies for each decile 
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of predicted probability. A Pearson chi-square statistic is used and the p-value calculated. 
The null hypothesis is that there is no difference between the observed and expected 
frequencies. A small p-value indicated that there are large differences in the observed and 
expected frequencies and the model is a poor fit while a large p-value cannot tell us that 
the model is a good fit just that we failed to find evidence of a poor fit.  
3.3.5.3 Outlying and Influential Observations 
Outliers are observations with large residuals (whose predicted and observed values 
greatly differ). Leverage measures how far an independent variable is from the mean 
value. Observations with high leverage can be problematic if they are also influential. 
This can occur when the observation with leverage is an outlier and removing the point 
significantly changes the regression coefficients.  
 Plots of the leverage, the change in Pearson chi-square statistic, deviance statistic, 
and the change in the beta coefficients all versus the predicted probabilities were used to 
assess outlying and influential points (Hosmer et al., 2013). Plots were also visually 
inspected to identify influential observations.  
3.3.5.4 Multicollinearity  
Multicollinearity occurs when the covariates have linear dependencies on each other. 
Multicollinearity can cause inflated standard errors and incorrect parameter estimates 
(Allison, 2012a). To investigate multicollinearity, the variance inflation factor (VIF), the 
amount by which the variance is inflated due to multicollinearity, was calculated for each 
independent variable in the model. A VIF of one indicates that the covariates are linearly 
independent (Mansfield & Helms, 1982). Covariates with a VIF greater than ten were 
investigated for possible removal from the model.  
3.4 Summary 
The purposeful selection approach allowed us to choose from amongst candidate 
variables, that were identified using literature review, to understand the factors that 
predict engagement in treatment amongst FEMAP patients.   
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Chapter 4  
4 Results 
FEMAP offered treatment to 366 patients, of whom 320 (87.4% [83.6, 90.4]) engaged in 
treatment and 46 (12.6%) did not. 
4.1 Sample Characteristics 
Sample characteristics are summarized in table 4.1. The study sample was mostly female 
(66.9%) with a mean age of 19.2 (SD 2.6). Approximately half of the sample (50.3%) 
was between the ages of 16 and 18. The majority identified their ethno-racial background 
as white (77.1%). More than half of the participants indicated their parents were married 
or living common law (55.0%), with the remainder indicating their parents were 
divorced, separated, or widowed. Participants who reported at least one parent had a 
college or university degree represented 75.4% of the sample. More than 80% of the 
patients arrived at FEMAP through non-traditional referral routes (e.g. self, high school 
guidance counsellor, community crisis services). Nearly three quarters of the participants 
(69.3%) drank four or fewer alcoholic beverages per occasion. Approximately one third 
of the participants (31.9%) reported using illicit drugs other than marijuana at least once, 
nearly two thirds (65.8%) reported ever using marijuana, and a little over half (51.9%) 
had smoked cigarettes or cigars at least once. Slightly more than half (51.8%) of the 
patients experienced low trauma exposure (zero or one type of traumatic experience). To 
ascertain satisfaction with previous mental health care participants were asked about 
treatment received before entering FEMAP. In response to the statement, “the mental 
health care I have received has been just about perfect”, Fifty-six (15.4%) participants 
chose the not applicable option. 12.4% of participants agreed or strongly agreed with the 
statement. The majority of respondents (87.6%) indicated they strongly disagreed, 
disagreed, or were uncertain in response to the statement. The p FEMAP sample had 
Anxiety Sensitivity Index (ASI-R) scores that ranged widely from 0 to 143 out of a 
possible 144 points. The mean total ASI-R score was 55.8 (SD 32.0). The mean total 
score on the Montgomery-Åsberg Depression Rating Scale (MADRS-S) was 12.3 (SD 
4.5). The mean total score on the Sheehan Disability Scale (SDS) 17.3 (SD 7.3) and the 
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mean score on the Inventory of College Students’ Recent Life Experiences (ICSRLE) 
was 105.7 (SD 23.4). 
Table 4.1 Sample Characteristics (N = 366) 
Variables  Mean (SD) or Number (%) 
(%) Age (N=366)  
 16 – 18 years 184 (50.3) 
 19 – 25 years 182 (49.7) 
Gender (N=366)  
 Male  121 (33.1) 
 Female 245 (66.9) 
Ethno-racial background (N=362)  
 White  279 (77.1) 
 Other 83 (22.9) 
Parents’ Marital/Cohabitation Status (N=360)  
 Married, common law or living together 198 (55.0) 
 Divorced, Separated, or widowed 162 (45.0) 
Parental education (N=358)  
 Less than a college or university degree 88 (24.6) 
 At least a college or university degree 270 (75.4) 
Referral (N=366)  
 Traditional (Physician) Referral 71 (19.4) 
 Non-traditional Referral 295 (80.6) 
Satisfaction with previous mental health care (N=363)  
 Not applicable 56 (15.4)  
 Not satisfied 269 (74.1)  
 Satisfied 38 (10.4) 
Quantity of Alcohol Typically Consumed per Occasion  
(N=362) 
 4 drinks or less 251 (69.3) 
 5 or more drinks 111 (30.7) 
Tobacco Use (N=364)  
 Never 175 (48.1) 
 Any use ever 189 (51.9) 
Marijuana Use (N=365)  
 Never 125 (34.3) 
 Any use ever 240 (65.8) 
Other Illicit Drug Use (N=364)  
 Never 248 (68.1) 
 Any use ever 116 (31.9) 
Trauma (N=363)  
 Low Trauma (0-1 types) 188 (51.8) 
 High Trauma (2-3 types) 175 (48.2) 
Severity of illness   
 Anxiety (ASI-R score) (N=366) 55.8 (32.0) 
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Variables  Mean (SD) or Number (%) 
(%)  Depression (MADRS-S score) (N=366) 12.3 (4.5) 
Functioning (SDS Score) (N=363) 17.3 (7.3) 
Daily Hassles (ICSRLE Score) (N=365) 105.7 (23.4) 
 
4.2 Missing Data 
Following imputation of missing questionnaire items, the frequency of missing values 
was investigated for each explanatory variable. No variable had more than 5% missing 
values. Pre-imputed values did not greatly differ from post-imputed values after using 
person mean substitution (see table 4.2).  
Table 4.2 Results of Questionnaire Imputation 
Questionnaire 
Pre-imputed 
value 
Mean (SD) 
Post-imputed 
value 
Mean (SD) 
Anxiety Sensitivity Index 55.6 (31.8) 55.8 (32.0) 
Sheehan Disability Scale 16.9 (7.3) 17.3 (7.3) 
Montgomery-Åsberg Depression Rating 
Scale 
12.3 (4.5) 12.3 (4.5) 
Inventory of College Students’ Recent Life 
Experiences 
105.3 (23.3) 105.7 (23.4) 
4.3 Cronbach’s alpha results 
The Cronbach’s alpha coefficient was calculated for each of the ICSRLE, MADRS-S, 
and ASI-R. Despite the changes made to the ICSRLE the alpha coefficient remained 
high; a value of 0.93 was found for the modified ICSRLE given to the participants of 
FEMAP. The alpha coefficient for the MADRS-S was calculated to be 0.84. The 
Cronbach’s alpha of 0.96 calculated from the ASI-R in this sample also demonstrates 
excellent internal consistency. 
4.4 Univariate Analyses 
The majority of FEMAP participants engaged in treatment; however, 46 (12.6%) 
participants did not engage and did not attend their first or any clinical appointments. 
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The results of the chi-square tests and t-tests for unadjusted associations between each 
covariate and the outcome are reported in table 4.3. Results of the univariate analysis 
indicated that only the total score on the ASI-R was significantly associated with 
engagement at the p<0.05 level. No other covariates were statistically significantly 
associated with engagement in FEMAP, although gender, quantity of alcohol consumed 
per occasion, and functioning were significant at the p<0.10 level. 
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Table 4.3 Univariate Analyses 
 
Engagement Status (N=366) 
p-value 
Characteristic 
Non-engaged 
n=46 (12.6%) 
Engaged 
n=320 (87.4%) 
Mean (SD) or 
Number (%) 
Mean (SD) or Number (%) 
Gender   0.0522 
 Female 25 (10.2) 220 (89.8)  
 Male 21 (17.4) 100 (82.6)  
Age   0.1242 
 16 to 18 years 28 (15.2) 156 (84.8)  
 19 to 25 years 18 (9.9) 164 (90.1)  
Ethno-racial 
background 
  0.3597 
 White 33 (11.7) 249 (88.3)  
 Other 13 (15.5) 71 (84.5)  
Parents’ 
Marital/Cohabitation 
Status 
  0.9338 
 Married 25 (12.4) 176 (87.6)  
 Unmarried 21 (12.7) 144 (87.3)  
Parental education   0.1937 
 Degree 31 (11.3) 244 (88.7)  
 No degree 15 (16.5) 76 (83.5)  
Referral   0.9757 
 Traditional referral 
(physician) 
9 (12.7) 62 (87.3)  
 Nontraditional 
referral 
37 (12.5) 258 (87.5)  
Satisfaction with 
previous mental 
health care 
  0.1084* 
 
 Not applicable 11 (19.6) 45 (80.4)  
 Satisfied 2 (5.3) 36 (94.7)  
 Not satisfied 33 (12.1) 239 (87.9)  
Quantity of Alcohol 
Consumed per 
Occasion 
  0.0723 
 4 drinks or less 26 (10.4) 225 (89.6)  
 5 or more drinks 19 (17.1) 92 (82.9)  
Tobacco Use   0.6024 
 Never 20 (11.4) 155 (88.6)  
 Any use ever 25 (13.2) 164 (86.8)  
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Engagement Status (N=366) 
p-value 
Characteristic 
Non-engaged Engaged 
Mean (SD) or 
Number (%) 
Mean (SD) or Number (%) 
Marijuana Use   0.6359 
 Never 14 (11.2) 111 (88.8)  
 Any use ever 31 (12.9) 209 (87.1)  
Other Illicit Drug Use   0.3635 
Never 28 (11.3) 220 (88.7)  
Any use ever 17 (14.7) 99 (85.3)  
Trauma   0.7536 
 Low trauma 25 (13.1) 166 (86.9)  
 High trauma 21 (12.0) 154 (88.0)  
Severity of Illness    
 Anxiety (ASI-R 
score) 
45.7 (29.7) 57.3 (32.1) 0.0214** 
 Depression 
(MADRS-S score) 
11.9 (4.2) 12.4 (4.6) 0.5486** 
Functioning (SDS 
Score) 
15.6 (7.5) 17.5 (7.2) 0.0981** 
Daily Hassles 
(ICSRLE Score) 
107.0 (21.9) 105.5 (23.6) 0.6820** 
*Fisher’s Exact Test used due to expected cell counts below 5 
**t-tests 
 
4.5 Associations Among Covariates 
4.5.1 Associations Among Continuous Covariates 
Pearson correlations illustrated that there were no strong linear associations among 
continuous covariates (ASI-R, MADRS-S, SDS, and ICSRLE scores.) (See Appendix K 
for detailed results.) 
4.5.2 Associations Among Categorical Covariates 
Chi-square tests showed that there were significant associations among categorical 
variables. All of the substance use variables were significantly associated with one 
another. Any use of one substance was associated with any use of another or with a 
higher quantity of alcohol consumption. Any usage of tobacco, marijuana, or other illicit 
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drugs was significantly associated with high trauma. Age group was also associated with 
all of the substance use variables, indicating that more of the 19 to 25 year olds had ever 
used tobacco, marijuana, or other illicit drugs, and drank more alcoholic beverages per 
occasion. Age group was also associated with ethno-racial background. A significantly 
greater proportion of 19 to 25 year olds identified their ethno-racial background as non-
white. Significantly more patients who reported ever using tobacco, marijuana, or any 
other illicit substance reported not being satisfied with previous mental health care. A 
significantly greater proportion of married parents also had at least a college or university 
degree or more education compared to unmarried parents. Significantly more patients of 
unmarried parents had experienced high trauma compared to patients of married parents. 
Significantly more patients of parents with less than a college or university education 
drank five or more alcoholic beverages per occasion and reported ever having used an 
illicit substance other than marijuana. (See Appendix L for detailed results.) 
 
4.5.3 Associations Among Continuous and Categorical Covariates 
T-tests revealed significant associations among continuous and categorical covariates. 
Gender was significantly associated with total ASI-R score, total ICSRLE score, and total 
MADRS-S score. Females had significantly higher ASI-R, ICSRLE, and MADRS-S 
scores compared to males. Patients of parents with less than a college or university 
degree had significantly greater functional impairment than patients of parents with a 
college or university degree. Patients of unmarried parents reported significantly greater 
functional impairment compared to patients of married parents. Patient who drank five or 
more alcoholic beverages per occasion had higher ICSRLE scores. Patients reporting any 
tobacco use ever had higher ASI-R, ICSRLE, and MADRS-S scores. Patients who had 
ever used marijuana had higher ICSRLE and MADRS-S scores compared to patients who 
had never used marijuana. Patients who had reported any illicit drug use other than 
marijuana also had higher ICSRLE and MADRS-S scores. Patients who had experienced 
high trauma also had significantly higher scores on the ASI-R and ICSRLE than those 
who had experienced low trauma. Satisfaction with previous mental health care was 
significantly associated with total MADRS-S score. Patients who reported being satisfied 
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with care also reported lower MADRS-S scores compared to those who reported not 
being satisfied with previous care or answered not applicable. Patients who reported not 
being satisfied with previous mental health care had significantly higher scores on the 
ICSRLE than those who were satisfied with previous care or answered not applicable. 
(See Appendix M for detailed results.) 
4.6 Purposeful Selection of the Logistic Regression 
Model 
In step 1 of the purposeful selection method, only the variables age, gender, parental 
education, total score on the ASI-R, total score on the SDS, quantity of alcohol consumed 
per occasion, and satisfaction had an association with engagement signified by a p-value 
below the cut-off of 0.25. In step 2, a multivariable model was fit with these variables. 
The variables age, parental education, satisfaction, and total score on the SDS were 
removed because the p-value in the multivariable model exceeded the 0.10 cut-off and 
removal of the variables did not change the coefficient estimates of any remaining 
variables by 15% or greater. In step 3, gender, total score on the ASI-R, and quantity of 
alcohol consumed were retained in the multivariable model. After testing each non-
candidate variable, no additional main covariates were added to the model. Thus, the 
preliminary main effects model included gender, ASI-R, and quantity of alcohol 
consumed. After testing interaction terms between gender and the other main effects, the 
interaction between gender and ASI-R was significant at p<0.05, and thus the interaction 
between ASI-R score and gender was added to the model. The final model is presented in 
table 4.4.  
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Table 4.4 Final Logistic Regression Model 
 Estimated 
Regression 
Coefficient 
p-value Odds 
Ratio 
95% Confidence 
Interval 
Gender     
 Male reference 
 Female 1.6842 0.0095 5.388* 1.509 19.237 
ASI-R Score 0.0346 0.0057 1.035** 1.010 1.061 
Quantity of Alcohol 
consumed per 
occasion 
    
 5 drinks or more -0.6790 0.0439 0.507 0.262 0.982 
 4 drinks or less reference 
Gender*ASI-R -0.0318 0.0247 - - - 
*at an ASI-R score of 0 
**odds ratio for unit increase in ASI-R score for males 
These results show that the odds of engaging in FEMAP is nearly 50% lower 
(95% CI [0.26, 0.98]) for an individual who drinks five or more alcoholic beverages per 
occasion compared to someone who drinks four or fewer per occasion. The presence of 
an interaction term between gender and ASI-R score indicates that the odds of engaging 
in FEMAP comparing females to males depends on the ASI-R score. When the ASI-R 
score is 0, the odds of a female participant engaging in FEMAP is more than five times 
(95% CI [1.51, 19.24]) the odds of a male participant engaging in FEMAP. However, as 
the ASI-R score increases, the odds ratio comparing female to male participants 
decreases. At around the median score on the ASI-R, the odds of a female or male 
participant engaging in FEMAP is equal. Beyond the median score, the odds of a male 
participant engaging in FEMAP is greater than the odds of a female participant engaging. 
The results are presented in table 4.5 and figure 4.1.  
Table 4.5 Odds Ratio Estimates and Confidence Intervals 
ASI-R score Estimated 
Odds 
ratio 
95% Confidence Limits 
Female vs male at ASI-R = 0 5.39 1.51 19.24 
Female vs male at ASI-R = 32 1.95 0.93 4.09 
Female vs male at ASI-R = 52.5 1.01 0.44 2.33 
Female vs male at ASI-R = 78 0.45 0.12 1.71 
Female vs male at ASI-R =143 0.06 0.003 1.16 
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Figure 4.1 Odds Ratio comparing females to males 
4.7 Model Fit and Diagnostics 
4.7.1 Assessing Linearity Assumption 
Visual inspection of the smoothed scatterplot (figure 4.2) assessing the linear association 
between ASI-R and the outcome confirmed the assumption that the total ASI-R score is 
linearly related to the log-odds of engagement. 
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Figure 4.2 Linearity of ASI-R 
4.7.2 Goodness of Fit 
The resulting p-value of 0.95 from the Hosmer-Lemeshow goodness of fit test indicates 
no evidence of a lack of fit of the model.  
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4.7.3 Outliers and Influential Observations 
 
Figure 4.3 Outlying and Influential Points 
Observation 271 was identified from the plots of the difference in the Pearson chi-square 
statistic, difference in deviance statistics, and the plot of the confidence interval (CI) 
displacements C plots as a potential outlier. Observation 69 was identified as a potential 
outlier from the plot of the CI displacements C plot. Observations 222, 120, and 176 were 
identified as potentially influential from the leverage plot. (See figure 4.3.) 
 All three observations with high leverage were male participants with low ASI-R 
scores. The refitted model after the removal of each of these observations resulted in a 
less than 20% change in any estimated coefficient. Upon inspection all observations had 
data within acceptable ranges and none were suspected of being incorrect. Therefore, no 
observations were removed from the analysis.  
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4.7.4 Multicollinearity 
The only variable with a variance inflation factor (VIF) greater than 10 was the 
interaction term. With interaction terms, a high VIF is anticipated and can be safely 
ignored (Allison, 2012b). (See table 4.6.) 
Table 4.6 Multicollinearity 
Variable Variance Inflation 
Factor 
Gender 3.9 
ASI-R Score 5.7 
Quantity of Alcohol 
Consumed 
1.0 
Gender*ASI-R 11.2 
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Chapter 5  
5 Discussion 
5.1 Summary of Study Findings 
FEMAP researchers collected a range of information on patients accepted into treatment 
covering some social and economic factors, patient-related factors, and condition-related 
factors. Using the literature as a guide, we selected key variables associated with 
engagement as potential risk-adjustment variables. Model selection revealed that female 
gender and anxiety sensitivity were positively associated with engagement and more than 
five quantity of alcohol consumed per occasion was negatively associated with 
engagement. We also identified a significant interaction between gender and anxiety 
sensitivity such that at low ASI-R scores, female patients were more likely to engage than 
male patients, but above an ASI-R score of 55, male patients were more likely to engage 
than female patients. All results reflect the effect of each variable after statistically 
controlling for other variables in the model. 
5.1.1 Descriptive Results 
We found an overall proportion of engagement of 87.4%. This is at the higher end of the 
proportions identified from the literature. A range of proportions from 33% to 78% have 
been previously reported (Baruch et al., 1998; Coletti et al., 2005; de Haan et al., 2015; 
DelBello et al., 2007; Fontanella et al., 2011; Ghaziuddin et al., 1999; Granboulan et al., 
2001; King et al., 1997; Laurier et al., 2010; Moses, 2011; Munson et al., 2010; Pelkonen 
et al., 2000; Stewart & Baiden, 2013; Timlin et al., 2014). The reason for our higher 
proportion of engagement is unknown, though a potential explanation involves our 
specific definition of engagement. As noted in the literature review, engagement has been 
defined in a variety of ways in the literature.  
 Our goal was to identify factors predictive of engagement in FEMAP. It is 
possible that the population of FEMAP differs from those in other treatment programs, in 
ways that increase the likelihood of engagement. FEMAP’s unique aspects, such as the 
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community-based setting and youth-friendly atmosphere may encourage engagement that 
is higher than studies in other treatment settings such as doctor’s offices and hospitals.  
5.1.2 Univariate Results 
Univariate results revealed that only one factor, a condition-related factor, the ASI-R 
score was significantly associated with engagement. Other patient and condition-related 
factors that were not significantly associated with engagement but were notable given a 
p-value less than 0.1 were gender, quantity of alcohol consumed per occasion, and 
functioning. Females, consumers of less than five alcoholic beverages per occasion, and 
those with higher functioning as indicated by the SDS score were more likely to engage.  
 Those arriving at FEMAP via physician referral had similar levels of engagement 
when compared to those arriving via a non-traditional referral, indicating no association 
between referral and engagement. This result is consistent with Pelkonen et al. (Pelkonen 
et al., 2000) but contrasts the findings of other research indicating that non-traditional 
referral is associated with greater engagement. (Baruch et al., 1998; Osuch et al., 2015). 
Within the non-traditional referral group, FEMAP researchers did not record whether the 
patient, a parent, or another health professional made initial contact. It is possible that 
individuals who make the initial contact are more motivated to attend treatment and have 
higher engagement but we were not able to test for potential difference in engagement at 
this level.  
5.1.3 Multivariable Results 
After purposeful selection, gender, ASI-R score, and quantity of alcohol consumed per 
occasion were included in a logistic regression model and each was found to be a 
significant independent predictor of the odds of engagement. We found gender to be 
associated with engagement, but the majority of studies identified in the literature did not 
find this association (Baruch et al., 1998; DelBello et al., 2007; Fontanella et al., 2011; 
Granboulan et al., 2001; King et al., 1997; Moses, 2011; Munson et al., 2010; Pelkonen et 
al., 2000; Stewart & Baiden, 2013; Timlin et al., 2014). 
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 We found a significant association between ASI-R score and engagement, unlike 
many studies that examined anxiety and its relationship to engagement (DelBello et al., 
2007; Fontanella et al., 2011; Ghaziuddin et al., 1999). Inconsistent findings may be due 
to differing measurements of anxiety. Other studies have used a clinical diagnosis of 
anxiety in contrast to the ASI-R score, which measures anxiety symptom severity as a 
continuous variable, used in our research. 
 We found an association between quantity of alcohol consumed per occasion and 
engagement. Our measure of quantity of alcohol consumed is consistent with the 
definition of binge drinking (Boak et al., 2015; Public Health Agency of Canada, 2016). 
Few studies investigated alcohol consumption as a predictor of engagement in this patient 
population. Stewart et al. investigated consumption of alcohol in the two weeks preceding 
admission but the variable was not significant in multivariable analyses (Stewart & 
Baiden, 2013). The reason for lower engagement among those who drink more alcoholic 
beverages per occasion is unknown; however, it is possible that this type of drinking 
behaviour is a coping mechanism that is being used to replace therapy, consequently 
leading to reduced engagement.  
 Notably, we found a significant interaction between gender and ASI-R score. In 
particular, at an ASI-R score of 0, females were more likely than males to engage (OR = 
5.388 95% CI [1.509, 19.237]). However, at an ASI-R score of 143, females were less 
likely to engage than males (OR = 0.057 95% CI [0.003, 1.159]). This result is consistent 
with Laurier et al. who found that anxiety predicted nonadherence in girls only (Laurier 
et al., 2010). The mechanism behind this finding is unclear. Anxiety may affect males 
and females differently, thus influencing the likelihood of engagement. It is possible that 
higher levels of anxiety in females leads to a greater motivation to engage in therapy and 
contacting several programs for treatment. Females with high anxiety may have been 
deterred by the increasing wait times at FEMAP and may have engaged in services 
elsewhere but were then designated as non-engagers at FEMAP. Studies have found that 
depressed females seek treatment in greater proportions than depressed males (Oliver, 
Pearson, Coe, & Gunnell, 2005; World Health Organization, 2001a); however, an 
Ontario-based study found that females were more likely to access services for mental 
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health reasons at ages 19 to 24 but no difference in access was found between males and 
females aged 15 to 18. (Cheung, Dewa, Cairney, Veldhuizen, & Schaffer, 2009).  
5.2 Study Strengths 
This research was strengthened by FEMAP researchers’ collection of data on sequential 
patients enrolled into the program, including a wide range of variable available for risk 
adjustment. Though numerous variables were available for inclusion, the initial selection 
of candidate variables was grounded in the literature. A thorough, systematic approach 
was used for model selection followed by exhaustive testing of model assumptions and 
fit. 
This research benefited from the low level of missing data. Redundant measures 
allowed for the use of logical imputation for some missing variables. Where logical 
imputation was not possible we used appropriate statistical imputation procedures for 
missing variables and missing questionnaire items so that all cases were included in 
analyses.  
5.3 Study Limitations 
Though this study had several strengths it is worth noting key limitations. This was a 
secondary, exploratory analysis of data so the data collection was not designed nor 
powered to look at factors associated with engagement. Several predictors were 
investigated increasing the risk of finding associations by chance; however, selection of 
predictors was based on a thorough literature review to minimize this risk. The limited 
sample size means that we may have had insufficient power to detect true associations.     
The definition of engagement may result in misclassification bias due to loss to 
follow-up. Patients who were classified in this study to have not engaged may have 
actually engaged in treatment elsewhere. Four patients who moved out of London were 
classified as non-engaged. It is not known whether these participants would have engaged 
had they stayed in London, Ontario. Sensitivity analysis excluding these patients had 
little effect on parameter estimates, and thus this potential misclassification does not 
affect the main study findings. 
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Some of the predictor variables differed from definitions or measurements used 
by other studies. The gender variable presented only male and female response options 
thus we cannot generalize this research to a non-cisgender population. The ethno-racial 
background variable did not include a Black Caribbean option; however, there was a free 
text field in which participants could indicate a Black Caribbean background. We were 
not able to investigate in more detail the effect of trauma history on engagement in 
particular, as the Trauma History Questionnaire (THQ) did not allow for timing to be 
deduced. In particular, we could not investigate the effect of childhood trauma because 
unlike the original version, FEMAP’s version of the THQ did not ask responders to 
indicate the specific age at which trauma occurred. When performing logical imputation 
for the THQ, we made assumptions about the reasons for missingness; however, we 
tested alternative assumptions and the impact on the THQ score was minimal. 
Previous literature indicated that SES could be a predictor of engagement (de 
Haan et al., 2015; DelBello et al., 2007; Munson et al., 2010; Pelkonen et al., 2000). Even 
though parental education is likely correlated with SES, in the absence of data on family 
income, we may have been unable to capture an association between SES and 
engagement.  
Previous literature found that substance use was associated with adherence; 
however, after investigating four variables, tobacco use, marijuana use, other illicit drug 
use, and quantity of alcohol consumed per occasion, only quantity of alcohol consumed 
was associated with engagement. It is possible that the dichotomization of the substance 
use variables diluted potential associations due to the heterogeneous nature of the any use 
ever grouping. 
Though the literature suggests that a positive attitude about treatment is associated 
with engagement (Munson et al., 2010; Pogge et al., 2005), we did not directly measure 
attitude.  We included satisfaction with previous mental health care as a proxy for a 
positive attitude about treatment assuming that those satisfied with past care are more 
likely to have a positive attitude about treatment. We also assumed that those who 
answered not applicable to the question, “The mental health care I have received has been 
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just about perfect”, did not previously receive mental health care. Cross-referencing with 
FEMAP data on receipt of previous care validated this assumption. It is also possible that 
participants who were included in the not satisfied group may have indicated satisfaction 
with previous mental health care had the question been worded more neutrally. This may 
have diluted any differences in engagement between the two groups, had they existed. 
It was not possible to conduct stratified analysis, examining predictors by 
diagnosis, because the diagnosis was not determined at intake. We were able to assess 
symptom severity through the MADRS-S and ASI-R scores. In addition, our findings on 
predictors of engagement are relevant to clinical practice, before a diagnosis can be 
established.  
We were not able to examine health system and health care team factors 
associated with engagement. There are aspects of the First Episode Mood and Anxiety 
Program that encourage engagement and reduce barriers to treatment at the system level. 
FEMAP is community-based, youth-friendly, allows for self-referral, and psychotherapy 
is provided for free whereas it can cost up to $200 elsewhere. Because the entire cohort 
accessed FEMAP and were thus exposed to these factors, their effect, if any, on 
engagement could not be investigated in this project.  
The generalizability of our results may be limited by several factors. The 
characteristics of the patient population in London, Ontario may differ from other 
settings. FEMAP treatment is provided as outpatient treatment only. Engagement in 
outpatient treatment may differ from engagement in inpatient care. FEMAP staff required 
each patient to participate in research in order to receive treatment and that may have 
influenced engagement. 
5.4 Recommendations for Future Research 
The current study defines engagement as attendance at the first clinical visit, after an 
extensive initial intake procedure. FEMAP patients may engage in treatment but may not 
remain engaged and may prematurely leave treatment. Future studies of the FEMAP 
population could investigate engagement in treatment over time. FEMAP continues to 
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collect data on all of its patients and can investigate the role of factors identified in this 
study on engagement in treatment over time, including gender, anxiety, and quantity of 
alcohol consumed per occasion. 
Future studies could also investigate level of engagement rather than as a 
dichotomous variable. The Service Engagement Scale is a service-provider rated scale 
that has been used to measure engagement with community mental health services in 
patients diagnosed with schizophrenia (Tait, Birchwood, & Trower, 2002).  There are 14 
questions divided into four subscales each rated on a four-point Likert scale. The 
subscales: availability, collaboration, help seeking, and treatment adherence, can provide 
more detailed information on specific areas of engagement.  
To address the limitations of a single center study, a multi-center study that 
compares FEMAP to other settings such as a general practitioner’s office would be very 
informative in answering whether FEMAP has better engagement than more traditional 
treatments. Atwood et al. sought to investigate factors associated with dropout from 
community mental health treatment and found the service factors played a greater role 
than patient factors in predicting dropout from treatment among adults with a diagnosis 
of schizophrenia, MDD, bipolar disorder, paranoia, or borderline personality disorder 
(Atwood & Beck, 1985).  
Future studies could also examine anxiety and gender, to see if our findings are 
generalizable to other populations. If gender and anxiety interact to affect engagement, 
future work could lead to a greater understanding of how anxiety influences engagement. 
This could lead to strategies that encourage engagement, particularly for females with 
high levels of anxiety.  
Our study was focused on individuals who had already decided to come to 
FEMAP and had completed the intake procedure at FEMAP. Population-based studies 
can identify mood and anxiety disorders in the community, giving insight to individuals 
in this age group with mood and anxiety disorders who did not access FEMAP or other 
care options in the first place. Studies can focus on access to therapy for youth with mood 
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and anxiety disorders to provide insights on removing barriers to access and increasing 
the availability of treatment in this population. 
5.5 Study Implications and Contributions 
This study provided much needed Canadian data on engagement to community-based 
mood and anxiety disorders treatment. The study also focused on important transitional 
ages when services change from child to adult and responsibilities may shift to the 
individual rather than a parent or guardian. This research added to the literature on the 
link between anxiety and engagement. In particular, it added information on how gender 
interacts with anxiety in predicting engagement. Laurier et al. was the first to highlight 
low levels of engagement for female patients with high anxiety (Laurier et al., 2010). The 
role of substance use was investigated in greater detail highlighting the importance of the 
number of alcoholic drinks consumed per occasion as a predictor of engagement. This 
measure of binge drinking was a stronger predictor than use of illicit substances such as 
marijuana and cocaine. 
5.6 Conclusion 
We have identified gender, anxiety, and quantity of alcohol consumed per occasion as 
important factors for determining engagement. This information can be used by FEMAP 
to identify those at risk of not following through with the first clinical appointment in 
order to facilitate improved engagement in therapy. Our findings also highlight other 
areas of research that can lead to a greater understanding of engagement in treatment for 
youth with mood and anxiety disorders.  
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Appendices 
Appendix A Descriptive Statistics – Age  
  Before Categorization After Categorization 
Age Frequency 
 
Percent Age Group Frequency 
 
Percent 
16 42 11.48 16 – 18 184 50.27 
17 78 21.31 19 – 25 182 49.73 
18 64 17.49 Frequency Missing = 0 
19 40 10.93 
20 30 8.20 
21 39 10.66 
22 24 6.56 
23 20 5.46 
24 11 3.01 
25 18 4.92 
Frequency Missing = 0 
 
Appendix B Descriptive Statistics – Ethno-racial Background 
  Before Categorization After Categorization 
Ethno-racial 
Background 
Frequency 
 
Percent Ethno-
racial 
Background 
Frequency 
 
Percent 
Aboriginal 5 1.38 White 279 77.07 
White 279 77.07 Other 83 22.93 
Black 9 2.49 Frequency Missing = 4 
Southeast/East Asian 13 3.59 
Other ethno-racial 
background 
20 5.52 
Multiple ethno-racial 
backgrounds 
36 9.94 
Frequency Missing = 4 
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Appendix C Descriptive Statistics – Parental Education 
  Before Categorization After Categorization 
Parental Education Frequency 
 
Percent Parental 
Education 
Frequency 
 
Percent 
Grade 9 2 0.56 Less than a 
college or 
university 
degree 
88 24.58 
Part of high school 8 2.23 College or 
University 
degree 
270 75.42 
High School Graduate 34 9.50 Frequency Missing = 8 
Part college or 
specialized training 
44 12.29 
College or university 
graduate 
202 56.42 
Graduate professional 
training 
68 18.99 
Frequency Missing = 8 
 
Appendix D Descriptive Statistics – Parental Marital Status 
  Before Categorization After Categorization 
Parental Marital 
Status 
Frequency 
 
Percent Parental 
Marital 
Status 
Frequency 
 
Percent 
Married 184 51.11 Married, 
Common 
law, Living 
together 
198 55 
Separated 68 18.89 Divorced, 
Separated, 
Widowed 
162 45 
Divorced 81 22.50 Frequency Missing = 6 
Widowed 13 3.61 
Common 
law/unmarried, living 
together 
14 3.89 
Frequency Missing = 6 
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Appendix E Descriptive Statistics – Marijuana Use 
  Before Categorization After Categorization 
Marijuana Use Frequency 
 
Percent Marijuana 
Use 
Frequency 
 
Percent 
Never Used 125 34.25 Never 125 34.25 
Tried but quit 83 22.74 Any usage 
ever 
240 65.75 
Several times a year 42 11.51 Frequency Missing = 1 
Several times a month 20 5.48 
Weekends only 17 4.66 
Several times a week 22 6.03 
Daily 33 9.04 
Several times a day 23 6.30 
Frequency Missing = 1 
 
Appendix F Descriptive Statistics – Other Illicit Drug Use 
  Before Categorization After Categorization 
Other Illicit Drug Use Frequency 
 
Percent Other Illicit 
Drug Use 
Frequency 
 
Percent 
Never Used 248 68.13 Never 248 68.13 
Tried but quit 66 18.13 Any usage 
ever 
116 31.87 
Several times a year 28 7.69 Frequency Missing = 2 
Several times a month 10 2.75 
Weekends only 3 0.82 
Several times a week 2 0.55 
Daily 7 1.92 
Several times a day 0 0 
Frequency Missing = 2 
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Appendix G Descriptive Statistics – Tobacco Use 
  Before Categorization After Categorization 
Tobacco Use Frequency 
 
Percent Tobacco 
Use 
Frequency 
 
Percent 
Never Used 175 48.08 Never 175 48.08 
Tried but quit 77 21.15 Any usage 
ever 
189 51.92 
Several times a year 23 6.32 Frequency Missing = 2 
Several times a month 16 4.40 
Weekends only 4 1.10 
Several times a week 13 3.57 
Daily 23 6.32 
Several times a day 33 9.07 
Frequency Missing = 2 
 
Appendix H Descriptive Statistics – Quantity of Alcohol Consumption 
  Before Categorization After Categorization 
Quantity of Alcohol Frequency 
 
Percent Quantity of 
Alcohol 
Frequency 
 
Percent 
1 drink 29 9.15 4 or fewer 
drinks 
251 69.34 
2 drinks 71 22.40 5 or more 
drinks 
111 30.66 
3-4 drinks 106 33.44 Frequency Missing = 4 
5-9 drinks 98 30.91 
10 or more drinks 13 4.10 
Frequency Missing = 49 
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Appendix I Descriptive Statistics – Satisfaction with Previous Mental Health Care 
  Before Categorization After Categorization 
Satisfaction Frequency 
 
Percent Satisfaction Frequency 
 
Percent 
Not applicable 56 15.43 Not 
applicable 
56 15.43 
Strongly Disagree 42 11.57 Not Satisfied 269 74.10 
Disagree 107 29.48 Satisfied 38 10.47 
Uncertain 120 33.06 Frequency Missing = 3 
Agree 36 9.92 
Strongly Agree 2 0.55 
Frequency Missing = 3 
 
Appendix J Descriptive Statistics – Trauma History  
  Before Categorization After Categorization 
Types of Trauma 
Experienced 
Frequency 
 
Percent Trauma 
History 
Frequency 
 
Percent 
0 75 20.66 Low trauma 188 51.79 
1 113 31.13 High trauma 175 48.21 
2 104 28.65 Frequency Missing = 3 
3 71 19.56 
Frequency Missing = 3 
 
Appendix K Associations Among Continuous Covariates (Pearson Correlation 
Coefficient) 
 ASI-R Score 
 
MADRS-S 
Score 
SDS Score ICSRLE 
Score 
ASI-R Score 1.00 0.39 0.31 0.39 
MADRS-S 
Score 
 1.00 0.55 0.51 
SDS Score   1.00 0.40 
ICSRLE Score    1.00 
ASI-R, Anxiety Sensitivity Index – Revised 36; SDS, Sheehan Disability Scale; ICSRLE 
Inventory of College Students’ Recent Life Experiences; MADRS-S, Montgomery-Åsberg 
Depression Rating Scale – Self Report 
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Appendix L Chi-square Tests of Association Among Categorical Covariates (p-
value) 
 Age  
 
Ethno-
racial 
backgro
und 
Parenta
l 
educati
on 
Parenta
l 
marital 
status 
Quantit
y of 
Alcohol 
Consum
ed 
Smoke Marijua
na 
Other 
illicit 
drugs 
Trauma Satisfac
tion 
Sex 0.7950 0.9516 0.7124 0.4862 0.1498 0.1689 0.5346 0.1321 0.2802 0.8652 
Age   0.0110 0.3617 0.7454 0.0013 0.0002 0.0001 0.0019 0.0066 0.8652 
Ethno-
racial 
backgr
ound 
  0.8680 0.6003 0.3741 0.6894 0.4201 0.1959 0.2288 0.5336 
Parent
al 
educati
on 
   0.0093 0.0401 0.4951 0.4985 0.0486 0.5509 0.7272 
Parent
al 
marital 
status 
    0.0107 0.1515 0.4867 0.6632 0.0042 0.3777 
Quanti
ty of 
Alcohol 
Consu
med 
     <0.0001 <0.0001 <0.0001 0.0010 0.6096 
Smoke       <0.0001 <0.0001 <0.0001 0.0003 
Mariju
ana 
       <0.0001
* 
<0.0001 0.0272 
Other 
illicit 
drugs 
        <0.0001 0.0152 
Traum
a 
         0.4392 
*Fisher’s Exact Test 
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Appendix M Between group differences in Continuous and Categorical Covariates 
(t-tests) 
Variable ASI-R 
p-value 
mean (SD) 
SDS 
p-value 
mean (SD) 
ICSRLE 
p-value 
mean (SD) 
MADRS-S 
p-value 
mean (SD) 
Age group 0.2292 0.1242 0.5562 0.8497 
16-18 53.80 (33.52) 16.67 (7.49) 106.4 (24.06) 12.35 (4.51) 
19-25 57.83 (30.26) 17.84 (6.98) 104.9 (22.76) 12.26 (4.50) 
Sex <0.0001 0.2850 0.0030 0.0455 
Male 43.48 (28.36) 16.67 (7.40) 100.5 (23.06) 11.63 (4.34) 
Female 61.89 (31.94) 17.54 (7.18) 108.2 (23.20) 12.63 (4.54) 
Ethno-racial 
background 
0.2344 0.4344 0.6805 0.3822 
White 56.89 (32.61) 17.41 (7.33) 105.4 (23.37) 12.42 (4.38) 
Other  52.16 (29.56) 16.71 (7.00) 106.6 (23.63) 11.93 (4.87) 
Parental 
education 
0.1651 0.0314* 0.4088 0.3020 
College or more 54.47 (31.89) 16.83 (7.51) 105.1 (23.61) 12.16 (4.61) 
Less than a college 
degree 
59.84 (32.01) 18.56 (6.19) 107.4 (22.78) 12.73 (4.11) 
Parental marital 
status 
0.3212 0.0493 0.2461 0.9816 
Married 54.30 (30.87) 16.58 (7.55) 104.4 (23.36) 12.30 (4.58) 
Unmarried 57.64 (33.25) 18.07 (6.80) 107.2 (23.43) 12.31 (4.40) 
Quantity of 
Alcohol 
Consumed per 
Occasion 
0.2839 0.9297 0.0011 0.0577 
4 or less 54.61 (32.45) 17.23 (7.07) 103.0 (23.18) 12.01 (4.52) 
5 or more 58.50 (30.79) 17.30 (7.66) 111.6 (22.90) 12.97 (4.39) 
Smoking 0.0231 0.4463 <0.0001 0.0007 
Never 51.87 (32.22) 16.95 (7.41) 100.6 (23.43) 11.48 (4.59) 
Any usage ever 59.45 (31.37) 17.53 (7.10) 110.3 (22.43) 13.07 (4.28) 
Marijuana 0.1196 0.1414 <0.0001 0.0118 
Never 52.21 (33.24) 16.48 (7.48) 98.60 (24.41) 11.49 (4.83) 
Any usage ever 57.69 (31.18) 17.65 (7.10) 109.4 (22.01) 12.73 (4.26) 
Other illicit drugs 0.3090 0.2376 0.0005 0.0342 
Never 54.64 (32.17) 16.94 (7.26) 102.8 (23.30) 11.96 (4.58) 
Any usage ever 58.29 (31.51) 17.90 (7.20) 111.8 (22.51) 13.03 (4.23) 
Trauma 0.0257 0.1738 <0.0001 0.2840 
Low trauma 52.24 (32.94) 16.76 (7.22) 99.81 (23.07) 12.06 (4.75) 
High trauma 59.69 (30.48) 17.79 (7.27) 112.1 (22.11) 12.57 (4.20) 
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Variable ASI-R 
p-value 
mean (SD) 
SDS 
p-value 
mean (SD) 
ICSRLE 
p-value 
mean (SD) 
MADRS-S 
p-value 
mean (SD) 
Satisfaction 0.0806 0.1932 0.3215 0.0002 
Not applicable 49.37 (29.96) 15.74 (7.48) 103.75 
(24.77) 
11.60 (4.63) 
Not satisfied 58.01 (32.30) 17.62 (7.12) 106.7 (23.64) 12.81 (4.32) 
Satisfied 49.51 (31.79) 16.83 (7.77) 101.2 (19.06) 9.74 (4.65) 
ASI-R, Anxiety Sensitivity Index – Revised 36; SDS, Sheehan Disability Scale; ICSRLE 
Inventory of College Students’ Recent Life Experiences; MADRS-S, Montgomery-Åsberg 
Depression Rating Scale – Self Report 
*t-test with unequal variances 
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